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ABSTRACT 
 
 
 Although the American Diabetes Association (ADA) adopted the use of the 
glycated hemoglobin (A1C) test as a method of diabetes and prediabetes diagnosis, the 
ADA has not developed firm guidelines concerning the use of the A1C test in children 
and adolescents, as research has not validated thresholds in this group.  Diabetes and 
prediabetes are diseases influenced by multiple factors, including race and ethnicity, age, 
vitamin D deficiency, and body mass index (BMI). 
 
The purpose of this study was to determine the sensitivity, specificity, positive 
predictive value (PPV), and negative predictive value (NPV) of the A1C test compared to 
the gold standard use of the fasting plasma glucose (FPG) and 2-hour oral glucose 
tolerance test (OGTT) to detect diabetes and prediabetes in a children and adolescents 
considered to be at higher risk for impaired glucose metabolism.  In addition, ROC curve 
analysis was performed to determine optimal thresholds for the diagnosis of prediabetes 
in available groups of the research sample.  The study also to examined the correlation 
between A1C and race and ethnicity, age, vitamin D levels, and body mass index, in 
addition to comparing the relationship of A1C to beta cell dysfunction and insulin 
sensitivity.  
 
A retrospective review of 902 patient electronic medical records in an urban 
endocrinology clinic was conducted.  Based on FPG and 2-hr glucose during the OGTT, 
patients were classified based on the ADA 2014 criteria as having diabetes or prediabetes  
Subjects ranged in age from 2-18 (11.6 ± 3.32), were predominantly minority (70.7% 
African American, 17.3% Hispanic, 12.0% Caucasian) and female (60.7%).  The results 
yielded a high specificity (99.7%) and high negative predictive value (99.9%) for the 
whole sample, although the results were lower for the African American group.  The 
results also yielded a low specificity (35.3%) but a high negative predictive value 
(99.8%) for the entire sample.  Although results were once again lower for the African 
American subset.  ROC curve analysis for prediabetes yielded a threshold of 5.8% for 
sample.  Multiple regression found some correlation between fasting glucose and A1C, 
although statistical analysis was not possible for the aggregate sample.  No statistically 
significant association was found between the A1C and age, vitamin D, and BMI in the 
sample. Correlation analysis found stronger associations between the A1C and beta cell 
dysfunction versus insulin sensitivity.   
 
In this predominantly minority population A1C had a high specificity and 
sensitivity for the diagnosis of diabetes.  While the A1C resulted in a high number of 
false positives for prediabetes, A1C <5.7% accurately identified individuals with normal 
glucose tolerance.  Children and adolescents considered to be at higher risk for impaired 
glucose metabolism (family history of diabetes, obesity, minorities, or history of 
gestational diabetes) with A1C ≥5.7% or with symptoms of diabetes should undergo 
OGTT testing.  In addition, different threshold levels for racial and ethnic groups should 
be considered in the diagnosis of prediabetes.  
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CHAPTER 1.    INTRODUCTION 
 
 
Background  
 
 Diabetes is a growing epidemic among children and adolescents in the United 
States.  A recent report from the Centers for Disease Control (CDC) noted that 23% of 
children in this country suffer from diabetes or prediabetes, which is an increase from 9% 
one decade earlier (CDC, 2012). The majority of the increase is directly linked to the 
increase in obesity, high fat diets, sedentary lifestyles among child and adolescents (May, 
Kuklina, & Yoon, 2012).  With the prevalence of diabetes and prediabetes growing, cost-
efficient and timely methods are needed to identify children and adolescents with the 
disease. Most criteria for the diagnosis of diabetes and prediabetes are based on adult 
values.  To date, there have been no systematic studies validating the appropriateness of 
glycated hemoglobin A1C (A1C) for use in children.  With the increased need to identify 
youth with this disease, the methods for diagnosis diabetes and prediabetes in younger 
groups should be further refined. 
 
The most common method to diagnose diabetes has been the oral glucose 
tolerance test.  More recently, the use of the (A1C) tests has been supported by several 
organizations.  However, the use of A1C testing to identify individuals at-risk for the 
development of diabetes has been controversial (ADA, 2007; McCarter, Hempe, Gomez, 
& Chalew, 2004). The International Expert Committee, appointed by the American 
Diabetes Association and European Association for the Study of Diabetes, concluded in 
2009 that A1C testing can effectively identify individuals at lower risk for developing 
diabetes (ADA, 2014). However, the committee did warn of limitations regarding the use 
of the test, including inconsistencies in correlating the A1C test to that of the fasting 
glucose results, the overall cost, and availability of the test.  Moreover, the committee 
found that the A1C tests do not accurately or precisely diagnose diabetes compared to 
other tests, such as oral glucose tolerance testing or average glucose concentrations 
(McCarter, Hempe, Gomez, & Chalew, 2004). 
 
The strength of A1C testing is that it most closely correlate with mean glucose 
concentrations over time, compared to the oral glucose tolerance test that correlates more 
closely with post prandial glucose concentrations (Nathan, Turgeon, & Regan, 2007; 
Rohlfing, et al., 2002) . In addition, A1C testing has been shown to be effective in 
predicting development of diabetes mellitus associated complications, such as the 
likelihood of developing diabetic retinopathy and nephropathy (Wang, et al., 2011). The 
test has also been most closely linked to morbidity and mortality rates among persons 
with diabetes mellitus (Boltri, Okosun, Davis-Smith, & Vogel, 2005).  However,  there 
have been mixed results showing the use of A1C with disease prediction methods.  Most 
research suggests prediction of diabetes mellitus is best done with challenged oral 
glucose testing in addition to A1C testing (Stern, Williams, & Haffner, 2002; Peter, et al., 
2007). As the cost of health care continues to rise, finding economically feasible 
prediction methods should be examined. 
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Little research exists with regard to the use of A1C testing in children or 
adolescents.  The International Committee (2009) recommended the A1C test be used in 
symptomatic adolescents.  However, limited research exists with its use in children (Lee, 
En-Ling, Tarini, Herman, & Yoon, 2011; Nowicka, et al., 2011).  In addition, thresholds 
for the use of the A1C tests were established in adults.  Appropriate thresholds have not 
been thoroughly researched in children or adolescents (Nowicka, et al., 2011).   
 
With regard to the accuracy of A1C testing, research has indicated several 
covariates influence A1C.  Racial and ethnic groups show statistically significant 
differences in the correlation of A1C to mean serum glucose concentrations (Herman, et 
al., 2007; Herman et al., 2009; Kirk, et al., 2008). Studies have shown variations in A1C 
among different racial groups, whereas mean plasma glucose concentrations do not vary 
between racial groups.  These preliminary results suggest a biological basis for the 
variability across racial groups with respect to A1C testing (Bonds, et al., 2003; 
Christensen, et al., 2010; Cohen, 2007). Vitamin D levels also have been correlated 
inversely to A1C, although the direct link between Vitamin D and diabetes has yet to be 
firmly established (Kositsawat, Freeman, Gerber, & Geraci, 2010).  In addition, some 
research suggests A1C differ based on beta cell function and insulin resistance (Kim, et 
al., 2012).  Research is needed to more clearly identify how these factors influence A1C, 
especially in children, so that appropriate guidelines can be established for the use of 
A1C test as a diagnostic test. 
 
 
Significance 
 
The current study was conducted to build on prior research exploring A1C and 
covariate factors.  However, this study examined individuals at earlier ages.  Most noted 
research on this topic used participants with mean ages ranging from 50-60 years (Boltri, 
Okosun, Davis-Smith, & Vogel, 2005; Christensen, et al., 2010; Kirk, 2008). Based on a 
review of data available, the mean age for this study will be significantly lower; 
specifically all participants will be age 0-18 years.  Thus, the results will show the 
relationship between A1C and covariates at younger ages where identification of at-risk 
individuals is crucial, as early detection and treatment of the disease has been shown to 
limit disease progression and physiological damage (Wang, et al., 2011). 
 
     Preliminary research calculated the sensitivity, specificity, positive predictive 
value, and negative predictive value of using the A1C compared to the OGTT in the 
diagnosis of diabetes and prediabetes.  In addition, the preliminary work examined the 
differences of the results between African Americans, Hispanics, and Caucasians in 
children, adolescents, and adults.  Although the results indicate low sensitivity and 
positive predictive value for the A1C, negative predictive values range from 92.8-98.3% 
for diabetes diagnosis and 87.0-97.7% for prediabetes diagnosis (Hitt et al., 2012), using 
the cut-off points suggested by the American Diabetes Association (ADA, 2012).  The 
significance of the higher negative predictive value is that threshold limits can be 
established to use A1C testing as a screening tool for additional diagnostic testing.  
Receiver operator characteristic (ROC) analysis suggests a cut-off of A1C level of 5.6% 
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for Caucasian and Hispanic individuals and 5.7% for African American when diagnosing 
prediabetes. By only performing OGTTs on individuals with A1C higher than 5.6% in 
Caucasian and Hispanic individuals and 5.7% in African Americans, analysis suggests a 
negative predictive value of 99.1% for individuals with diabetes and 95.2% for 
individuals with prediabetes (Hitt et al., 2012).  By using the A1C test as a screening tool, 
fewer individuals will need to undergo the OGTT, which is a time-consuming, costly, and 
poses higher risk to the individual. 
 
 
Purpose of the Study 
 
 The purpose of this study is to establish the accuracy of A1C testing in children 
and adolescents at-risk for diabetes and prediabetes, identify factors that may alter its 
accuracy, and determine if a relationship exists between A1C and insulin levels. 
 
 
Specific Aims and Research Questions 
 
 The following were the three specific aims and related research questions of this 
study: 
 
 Specific aim 1:  To determine the accuracy of the A1C test to diagnose diabetes 
and prediabetes in a sample of children and adolescents identified as at-risk for 
diabetes and prediabetes. 
 
1.1  What is the sensitivity, specificity, positive predictive value, negative 
predictive value, and ROC curve analysis for the overall sample? 
1.2 What is the sensitivity, specificity, positive predictive value, negative 
predictive value, and ROC curve analysis for each ethnic/racial group 
(African American, Hispanic, and Caucasian)? 
1.3 What are the sensitivity, specificity, positive predictive value, negative 
predictive value, and ROC curve analysis for each age group (0-5 years, 6-
11 years, 12-18 years)? 
 
 Specific aim 2:  To determine factors influencing A1C that may alter the 
accuracy of the A1C test to effectively diagnose diabetes and prediabetes in 
children and adolescents. 
 
2.1 What is the relationship between BMI, family history, age, race/ethnicity, 
fasting plasma glucose, 2-hour OGTT, and vitamin D levels on the A1C 
level? 
 
 Specific aim 3:  To determine the relationship of beta cell function and insulin 
resistance to A1C in children and adolescents. 
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3.1  What is the correlation between insulin levels and beta cell function during a 
2 hour OGTT and A1C results?  
 
 
Operational Definitions 
 
 Adolescent is an individual who is older than 12 years (144 months) of age but 
younger than 18 years (216 months) of age at the time of the diagnostic testing. 
 
 Beta Cell Dysfunction is a condition which the beta cells of the pancreas fail to 
produce sufficient insulin.  The severity of beta cell dysfunction is measured by insulin 
levels (ADA, 2014) 
 
 Body Mass Index (BMI) is a score calculated by the participant’s height and 
weight.  For the purpose of this study, it was used to approximate body mass and to 
identify participants who were overweight or obese. 
 
 Child is an individual younger than 12 (144 months) years of age at the time of 
the diagnostic testing.   
 
 Diabetes is a metabolic disease characterized by hyperglycemia.  For the purpose 
of this study, it is a classification given to participants with a FPG  ≥ 126 mg/dl or a 2-
OGTT ≥ 200 mg/dl, in accordance with the ADA Diagnostic Guidelines (2014).  For the 
purpose of this study T1DM and T2DM were classified the same.   
 
 Diabetes Type I (T1DM) is a type of diabetes mellitus that is caused by injury to 
the beta cells in the pancreas that render the cells unable to produce insulin.  For the 
purpose of this study, ADA (2014) guidelines for diagnosing diabetes will be used.  
There will not be a differentiation between T1DM and T2DM. 
 
 Diabetes Type II (T2DM) is a type of diabetes mellitus that is caused by 
decreased sensitivity of tissue to insulin.  The condition is marked by hyperinsulemia.  In 
later stages of the disease, beta cells become impaired and are unable to produce insulin 
in the quantities needed for glycemic control.  For the purpose of this study, ADA (2014) 
guidelines for diagnosing diabetes will be used.  There will not be a differentiation 
between T1DM and T2DM. 
 
 Fasting Plasma Glucose (FPG) is a lab test that measured the plasma glucose 
concentrations in participants after at least 8 hours of fasting from food or drink (ADA, 
2014). 
 
 Gender is either male or female and was participant or guardian-reported. 
 
 Glycemic Control is the biological process of controlling glucose concentrations 
within the body.  Glycemic control is an individualized concept, and definitions of 
control will vary based on the presence of disease.  For non-diabetic individuals, 
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glycemic control is defined as blood glucose concentrations between 70-130 mg/dl pre-
prandial, blood glucose concentrations less than 180 mg/dl 2-hours post-prandial, and a 
A1C level less than 6.5% (ADA, 2014) 
 
 Glycated Hemoglobin or A1C (A1C) is a form of hemoglobin that measures the 
average plasma glucose concentrations over time.  The ADA (2014) measures A1C >6.5 
% as a positive test for diabetes, whereas A1C between 5.7-6.4% measure as a positive 
test for prediabetes. 
 
 Insulin Resistance is the body’s inability to utilize insulin.  It was calculated in 
this study using the quantitative insulin-sensitivity check index (QUICKI).  Research 
suggests a find of <0.3 is equivalent to insulin resistance (Velasquez-Mieyer, et al., 
2008). 
 
 Oral Glucose Tolerance Test (OGTT) is a test for the diagnosis of diabetes or 
prediabetes.  Serum glucose concentrations are obtained at fasting.  After the intake of a 
75 gram glucose solution, serum glucose concentrations are tested at 30 minutes, 60 
minutes, 90 minutes, and 120 minutes post intake (ADA, 2014). 
 
 Prediabetes is a classification given to participants with a FPG 100-125 mg/dl or 
a 2-OGTT 140-199 mg/dl, in accordance with the ADA Diagnostic Guidelines (2013).  
Prediabetes is also termed “impaired glucose tolerance”. 
 
 Race/Ethnicity is based off a participant self-reporting or guardian-reporting on 
the patient medical record.  Participants were classified as African-American, Caucasian, 
or Hispanic based off of the medical record.  Participants identified as multiracial were 
excluded from the study.  Participants with race/ethnicity identified as anything other 
than African American, Caucasian, or Hispanic were excluded from the study.   
 
 Vitamin D is a fat-soluble corticosteroid that plays a role in the development of 
diabetes.  Research is limited to its role, other than some studies that suggest vitamin D 
deficiency increases the likelihood of diabetes development.  Vitamin D levels were 
tested using the 25-hydroxyvitamin D test.  Optimal levels of vitamin D in children and 
adolescents are 50-75 ng/ml, while levels less than 11 ng/ml are considered deficient 
(CDC, 2011). 
 
 
Assumptions 
 
 The framework for this study is grounded in the following assumptions: 
 
1.  The “gold standard” for the diagnosis of diabetes and prediabetes is the oral 
glucose tolerance test. 
2.  Participants fasted from food or drink for a minimum of 8-hours prior to all 
testing. 
3.  Laboratory data were obtained and recorded accurately for each participant 
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4.  Participants information retrieved from participant or guardian health interviews 
was accurately reported. 
5.  Laboratory tests were collected via standard agency collection policies. 
 
 
Limitations 
 
 The following limitations were identified in the study: 
 
1.  Data were obtained from one clinic in the same geographical area.  Results may 
not be generalizable to other areas or to other clinics. 
2.  A secondary data analysis was performed on a prospective study, which limited   
particular information from being collected. 
3.  Normative values for A1C in children and adolescents are not known.   
4.  Data were obtained only from children and adolescents with noted risk factors for 
diabetes or prediabetes.  Children and adolescents without risk factors for diabetes 
or prediabetes were not tested. 
 
 
Conceptual Framework 
 
As outlined in Figure 1-1, the developed framework aligns with the study aims, 
as it connects the known factors influencing glycemic control to diabetes, prediabetes or 
no-disease.  The framework begins with a wheel that identifies factors known to 
influence glycemic control.  The wheel includes the variables that will be examined in the 
study, specifically, race/ethnicity, age, insulin resistance (insulin levels), vitamin D, and 
obesity (body mass index). In addition, the wheel includes variables that are not 
examined in this study, but do impact glycemic control.  These shaded variables include 
physical activity, magnesium deficiencies, family history, diet, autoimmune disorders, 
hormonal disorders, and infection.  The interior of the wheel is connected via arrows, 
which indicates the variables are connected and have the potential to influence each 
other. 
 
 The wheel points to a see-saw that depicts glycemic control.  As glycemic control 
is a dynamic condition, it is placed on a lever balanced on a fulcrum.  To the left of the 
fulcrum lies the area of disease, which is diabetes or prediabetes.  To the right of the 
fulcrum lies the area of no-disease.  Under glycemic control are the diagnostic tests that 
are used to measure glycemic control, specifically the OGTT and A1C. 
 
 The lever/fulcrum system most importantly indicates that the disease process is a 
dynamic state.  Individuals can often move the direction of the lever by adjusting the 
factors in the wheel. Factors that limit glycemic control will position the lever in favor of 
disease, while factors that promote glycemic control will position the lever in favor of no-
disease.  As outlined in the framework, the severity and presence of the disease can be 
attenuated by the factors in the wheel. Moreover, glycemic control is measured with the 
gold standard OGTT and the A1C.  
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Figure 1-1. Glycemic control concept map 
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Diabetes 
 
 The causes of diabetes are complex.  T1DM has a genetic and vitamin D 
deficiency link, although research shows most often it is caused by autoimmune disorders 
and/or viral infections that attack beta cells within the pancreas, rendering the beta cells 
unable to produce insulin and also causing alpha cell dysfunction.  As a result of beta cell 
dysfunction, lypolysis occurs, which stimulates increased glycerol, and gluconeogensis.  
Individuals with T1DM develop low insulin levels and are unable to achieve glycemic 
control without medication (Jones, Brashers & Huether, 2010). 
 
 T2DM has a variety of causes, most often directly linked to obesity, physical 
inactivity, and diet.  Impaired insulin release in the pancreas, due to beta cell dysfunction, 
insulin resistance by muscle tissue, or decreased insulin clearance leads to 
hyperinsulemia.  These individuals may be able to achieve glycemic control via lifestyle 
medications and diet.  However, medication is often required to achieve glycemic control 
(Jones, Brashers & Huether, 2010). 
 
 
Testing for diabetes 
 
 A full clinical assessment of an individual for diabetes will include a variety of 
assessments tools, including many laboratory tests.  The gold standard used to diagnose 
diabetes has been the oral glucose tolerance test.  Positive fasting plasma glucose or 
positive 2-hour results will trigger a diagnosis of diabetes or prediabetes.  More recent 
research has suggested high A1C also validate the diagnosis of diabetes (Jones, Brashers 
& Huether, 2010). 
 
 Additional tests are warranted to determine the cause of the disease.  These tests 
include insulin levels, specific antibodies, genetic testing, c-peptide levels, hepatic 
function, kidney function, triglyceride panels, vitamin D, and magnesium.  These tests 
are not used to diagnose diabetes, but rather are used to identify the cause of the disease 
(Jones, Brashers & Huether, 2010). 
 
 
Glycemic control 
 
 Glycemic control is achieved in individuals with diabetes primarily through 
medical intervention, although diet and lifestyle changes can also impact glucose 
concentrations.  Glycemic control is often determined on an individual basis.  The 
conceptual model shows how glycemic control is a dynamic state that is altered with 
changes in medication, diet, and lifestyle interventions.   
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Summary 
 
 In summary, this chapter provided an introduction to the concept of A1C testing 
as screening and diagnostic testing for diabetes and prediabetes in children and 
adolescents.  This chapter discussed the purpose, aims, and specific research questions 
that will seek to identify more clearly the relationship between A1C and various 
covariates. Chapter 2 will focus on the review of literature for all the proposed research 
questions, while chapters 3-5 will provide the results and discussion for the proposed 
research questions. 
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CHAPTER 2.    LITERATURE REVIEW 
 
 
Introduction 
 
 The protocols for screening, diagnosis, and identification of individuals at-risk for 
diabetes and prediabetes are changing.  Past policies focused exclusively on tests that 
examined glucose in blood serum, such as the fasting blood glucose and 2 hour oral 
glucose tolerance test (OGTT) (ADA, 2013; ADA 2007).  New research has shown 
hemoglobin A1C assay (A1C) testing to be effective at diagnosing diabetes (Lindstrom et 
al., 2003; Willis et al. 2007)  However, limited evidence exists that demonstrates the 
effectiveness of using A1C to screen or identify individuals with impaired glucose 
tolerance (Rohlfing et al., 2002; Stern, Williams, Haffner, 2002).  Moreover, research has 
shown differences in A1C between races after adjusting for covariates (Boltri et al., 2003; 
Christensen et al., 2010).  A review of current literature shows a gap in research 
concerning the use of A1C for the testing of diabetes and prediabetes in children and 
adolescents.  This review will focus on the A1C as a diagnostic test for diabetes and 
prediabetes in youth, the relationship of A1C to other factors and potential covariate, and 
the relationship between A1C and beta cell dysfunction and insulin sensitivity. 
 
 
Diabetes and Prediabetes Screening Tests 
 
 The current standard for the screening and diagnosing of diabetes and prediabetes 
is the oral glucose tolerance test (ADA, 2013).  Current trends have focused on the use of 
A1C testing to screen and diagnose individuals for diabetes.  However, research has 
shown the A1C test to be accurate and precise for the diagnosis of diabetes only when 
A1C exceed 6.5% (Cowie et al., 2010; Peter et al., 2007; Wang et al., 2002).  Limitations 
still exist when using the test alone to identify individuals with impaired glucose 
tolerance.  Individuals with levels below 6.5% are generally not diagnosed with diabetes.  
However these same individuals may be a risk for developing diabetes. Early detection of 
pre-diabetes could lead to measures to halt disease progression and complications.   
(McCarter, Hempe & Chalew, 2006).  Early detection of the diseases could lead to 
implementation of measures to halt disease progression, which could limit the 
complications of the diseases.  
 The use of A1C testing to identify individuals at-risk for the development of 
diabetes has been controversial (ADA, 2007; McCarter, Hempe, Gomez & Chalew, 
2004). The International Expert Committee, appointed by the American Diabetes 
Association and European Association for the Study of Diabetes, concluded in 2009 that 
A1C testing can effectively identify individuals at lower risk for developing diabetes 
mellitus (McCarter, Hempe, Gomez & Chalew, 2009).  However, the committee did warn 
of limitations regarding the use of the test, including inconsistencies in correlating the 
A1C test to fasting glucose results, and the overall cost and availability of the A1C test.  
Moreover, the committee found that the A1C tests do not accurately or precisely diagnose 
diabetes compared to other tests, such as oral glucose tolerance testing or average glucose 
concentrations (McCarter, Hempe, Gomez & Chalew, 2004).    
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 Research studies have pointed to individual differences in the correlation between 
glucose concentrations and A1C.  Cohen, Holmes, Chenier & Joiner (2003) found a 
higher correlation level (R2 > 0.98) within-person between A1C and fructosamine.  This 
study validated the concept that A1C vary substantially between individuals for a variety 
of factors, most noticeably due to intracellular glycation.  Twin studies further suggest 
A1C are not entirely associated with glucose concentrations (Sneider et al., 2001; 
Simonis-Bik et al., 2008; Cohen et al., 2006).  Research suggests multiple factors affect 
A1C, and clinicians should take these factors into consideration when diagnosing and 
screening for diabetes and prediabetes (Herman & Cohen, 2010). 
 
 The strength of A1C testing is that it has been shown to most closely correlate 
with mean glucose concentrations over time (Nathan, Turgeon & Regan, 2007; Rohlfing 
et al., 2002).  Rohlfing et al. (2002) conducted a pioneer study that analyzed the 
relationship between plasma glucose and A1C.  Using a multicenter, randomized clinical 
trial, the investigators found a predictable relationship between plasma glucose 
concentrations and A1C in adults.  These findings were later used by the ADA to develop 
the criteria for the use of A1C as a diagnostic test (ADA, 2012).  Nathan, Turgeon & 
Regan (2007) validated findings from the Rohlfing et al. (2002) study when it found A1C 
closely correlating to average plasma glucose concentrations.  Although the Nathan, 
Turgeon & Regan (2007) sample was small (N=22), the study used continuous glucose 
monitoring, which measured interstitial glucose concentrations every 5 minutes for 84 
days.  This study was also used by the ADA in the development of the criteria for use of 
A1C testing for prediabetes and diabetes diagnoses. 
 
 A1C testing has been shown to be effective in predicting disease development in 
those with diabetes mellitus, such as the likelihood of developing diabetic retinopathy 
and nephropathy (Wang et al., 2011).  It has also been most closely linked to morbidity 
and mortality rates in diabetes mellitus (Boltri, Okosun, Davis-Smith & Vogel, 2005). 
However, the use of A1C with disease prediction methods has yielded mixed results.  
Some research suggests prediction of diabetes mellitus is best done with challenged oral 
glucose testing, in addition to A1C testing (Stern, Williams & Haffner, 2002; Peter et al., 
2007). 
 
 However, research has also validated the use of A1C testing as a screening tool 
(International Expert Committee Report, 2009).  In a multiethnic systematic review of 
adults, Bennett et al. (2010) found an A1C of greater or equal to 6.1% had a sensitivity of 
78-91% and a specificity of 79-84% compared to the oral glucose tolerance test in adults.  
In contrast, research from the National Health and Nutrition Examination Survey III 
(NHANES III) showed an A1C greater or equal to 6.5% had a sensitivity of 44% and a 
specificity of 99%  The International Expert Committee Report (IECR) (2009) purported 
that no single test can be considered a gold standard.  Kramer, Araneta & Barrett-Conor 
(2010) corroborated the IECR report when they concluded that the use of an OGTT alone 
would fail to identify high percentages of adults with A1C greater or equal to 6.5%. 
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A1C in Children and Adolescents 
 
 The ADA currently recommends screening for type 2 diabetes in asymptomatic 
adolescents, if their BMI is greater or equal to the 85% percentile, and the adolescent has 
2 or more risk factors for the disease.  Risk factors can include family history, at-risk 
racial/ethnic group, conditions or signs of insulin resistance, small for gestational age at 
birth, or maternal history of gestational diabetes.  The ADA further recommends 
screening tests to be limited to FPG, due to cost and convenience (ADA, 2013).  The 
International Diabetes Federation (IDF) has yet to endorse the use of A1C testing for 
adolescents or children, although it has endorsed its use for adults (Nowicka at al., 2011).   
There is a paucity of research regarding the clinical utility of A1C to detect diabetes and 
prediabetes in children and adolescents. 
 
 Nowicka et al. (2011) provides the most comprehensive study to-date on the use 
of A1C for the diagnosis of diabetes and prediabetes.  In a multiethnic cohort of obese 
subjects under 18 years of age (N=1,156), the ADA guidelines of a 6.5% A1C 
underestimated the prevalence of diabetes and prediabetes in adolescents and children.  
Using receiver-operator curve (ROC) analysis, Nowicka et al. (2011) found that the 
optimal A1C threshold to identify diabetes in obese children and adolescents was 5.8%, 
while the optimal threshold for the diagnosis of prediabetes was 5.5%.  Although this 
study did not stratify for racial or ethnic differences in the ROC curves, the study 
concluded that A1C values may be most useful in screening children and adolescents, but 
it casts doubt on applying adult diagnostic criteria for diabetes to younger populations. 
 
 Lee et al. (2011) validated results from the Nowicka et al. (2011) study, finding 
low sensitivity (75%) but high specificity (>99%) when using A1C for diagnosing 
diabetes and prediabetes in adolescents compared to fasting plasma glucose (FPG).  Lee 
et al. (2011) utilized NHANES data for individuals between 12-19 years of age and an 
adult sample.  The positive predictive ability of A1C for prediabetes based on ROC curve 
analysis was low for both FPG (AUC:  0.61) and 2-hr OGTT post-prandial glucose 
(AUC:  0.53).  However, the lower prevalence of the DM and prediabetes in the 
childhood and adolescent population made it difficult to correlate adult diagnostic criteria 
to other populations (Lee et al., 2011) 
 
 The correlation between plasma glucose and A1C also has been shown to differ 
between adults and youth.  Ogawa et al. (2012) examined school-aged children (mean 
age=11.9 ± 2.5 yrs) in Japan (N=298) and found FPG levels were not as highly correlated 
to A1C, when compared to adult counterparts.   In the sample school-age children group, 
an A1C of 6.5% correlated to a FPG=111.4 mg/dL, while previous research in adults 
found correlation in adults to be 124.4 mg/dL (Seino et al., 2010).  As a result, 
standardized scales correlating A1C to plasma glucose concentrations should be 
reanalyzed for children and adolescents.   
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Factors Influencing A1C 
 
 
Racial and ethnic factors 
 
 Racial and ethnic groups show statistically significant mean differences and 
variation in A1C in adults and children (Herman, et al., 2007; Herman et al., 2009; Kirk, 
et al., 2008). Studies have shown variations in A1C among different racial groups, 
whereas mean plasma glucose concentrations do not vary between racial groups.  These 
results suggest a biological basis for the variability across racial groups with respect to 
A1C testing (Bonds, et al., 2003; Christensen, et al., 2010; Cohen, 2007).  
 
 Kirk et al. (2005) used a meta-analysis (N=21) to examine A1C across minority 
and ethnic groups.  The review concluded that African Americans and Hispanic 
populations have poorer glycemic control and higher A1C than compared to the non-
Hispanic white counterparts.  Herman et al. (2007) compared A1C from 5 different racial 
and ethnic groups.  Using an adult sample (N=3,819), the study found A1C were higher 
in racial and ethnic minorities. The difference in A1C was particularly high among 
African American and Hispanic subjects.  This research concluded that the differences 
between racial and ethnic groups were consistent across previous research studies.   
 
 Herman et al. (2009) further examined the racial and ethnic difference in A1C 
when compared to mean plasma glucose concentrations.  Using a multicenter sample of 
adults from 11 countries (N=2094), the study found difference between racial and ethnic 
groups for A1C and 1,5-anhdroglucitol levels, but not for mean plasma glucose 
concentrations.  The research concluded that criteria established for the diagnosis of 
diabetes based on A1C might be challenging due to inherent differences between racial 
and ethnic groups (Boltri et al., 2003; Christensen et al., 2010; Herman et al., 2009). 
 
 
Vitamin D deficiency 
 
 Recent research has focused on the role of Vitamin D in diabetes (Takiishi et al., 
2010).  Vitamin D deficiency has a suspected role in the development of T1DM and in 
the functional ability of beta cells in T2DM (Badawi, Sayegh, Sadoun, At-Thain, Arora, 
Hadad, 2014).  According to Yiu et al. (2011), there is a significant correlation between 
vitamin D deficiency and A1C.  A prospective study by Forouhi et al. (2008) reported an 
inverse relationship between vitamin D levels and future insulin resistance.  Baseline 
vitamin D insufficiency was correlated a 10 year risk of increased fasting glucose 
concentrations, 2 hour-glucose concentrations, and a metabolic syndrome risk factor 
score.  A recent prospective study focusing on youth newly diagnosed with diabetes also 
reported similar results.  Doga et al. (2014) reported 91.9% of newly diagnosed youth 
with diabetes (n=72) had vitamin D deficiency, whereas only 58.5% of non-diagnosed 
individuals in the control group (n=42) had vitamin D deficiency (p value=0.01).  Bayani 
et al. (2013) validated previous research when they reported similar findings in vitamin D 
levels between a group of matched diabetes cases and non-diseased subjects.  The mean 
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concentration of vitamin D in the case group was 18.7 ± 10.2 ng/dl, whereas the mean 
concentration in the control group was 24.6 ± 13.5 ng/dl (p=0.002).   
 
NHANES data indicate vitamin D deficiency in the southern United States is 
estimated to be 53-76% for non-Hispanic blacks compared to 8-33% for non-Hispanic 
whites (Looker, et al. 2002).  With multiple studies indicating a connection between A1C 
and vitamin D deficiency, in addition to the knowledge that African Americans often 
exhibit greater rates of vitamin D deficiencies, a connection could exist between lower 
vitamin D levels and higher A1C in African Americans.  
 
 
Age 
 
 Evidence suggests age plays a role in the acceleration of the diabetes disease 
process, with youth experience greater complications and inabilities of glycemic control 
(Narasimhan & Weinstock, 2014).  Limited research has explored the effects of age on 
A1C.  Moreover, ADA guidelines for diabetes and prediabetes diagnosis has been limited 
to testing in the adult population (ADA, 2014).  With regard to youth, evidence suggests 
puberty plays a role in the development and progression of the disease, as complications 
are hastened during this timeframe (Cho, Craig, Donaghue, 2014).  Additional research is 
needed to set appropriate A1C level diagnostic cut-offs that more accurately reflect 
disease state in a youth population. 
 
 
Lifestyle factors and obesity 
 
 Research has supported the concept that multiple metabolic, physiological, and 
lifestyle factors exist that influence serum glucose and A1C (Maruther et al., 2011).  
Factors include genetic predispositions to increased plasma glucose and conditions that 
increase binding affinity between hemoglobin and glucose (Soranzo, et al., 2010).  In 
addition, research has identified factors that explain the difference in A1C between racial 
and ethnic groups that include lifestyle choices and health disparities (Maruther et al., 
2011).  Most research focuses on lifestyle choices, such as diet and exercise, and their 
impact on glucose concentrations. However, little research has focused on the effects of 
diet and exercise directly on the A1C.  
 
 
Genetic disposition and family history 
 
 Genetic predisposition to higher glucose concentrations in African American and 
Hispanic groups have been identified, and it is known that naturally higher mean plasma 
glucose level will inherently lead to a higher A1C level.  Soranzo et al. (2010) showed a 
genetic link that affects the ability of ambient plasma glucose and intracellular 
cytoplasmic glucose to bind, which increases the ratio of glucose to hemoglobin, thus 
increasing A1C.  The research examined 46,368 nondiabetic adults of European descent.  
Using a meta-analysis, the research identified 10 genetic loci that are associated with 
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A1C.  Soranzo et al. (2010) recommended a reclassification of diabetes diagnosis based 
on A1C. 
 
 Research has also shown genetic variations that cause non-glycemic changes that 
also impact A1C. According to Meigs et al., (2002), the heritability of A1C is higher 
(47%-59%) than the heritability of fasting glucose (34%-36%) and the 2-hour result of 
the OGTT (33%), results that were validated with the findings of Herman et al. (2009). 
These results indicate A1C variation between racial groups is not necessarily a result of 
higher mean plasma glucose rates, but rather a result of binding affinity between the 
hemoglobin and glucose.  Changes in binding affinity have been noted in several medical 
conditions, including hemoglobinopathies often found in African Americans (Jones, 
Brashers & Huether, 2010).  The higher rates of certain medical conditions in African 
Americans and Hispanic people have been shown to impact A1C (Soranzo, et al., 2010).  
African Americans and Hispanic people have noted differences in erythrocyte turn-over 
and hereditary anemias.  In addition, African Americans have higher rates of hemolytic 
anemias, chronic malaria, and hemoglobinopathies, which can increase A1C (Herman et 
al., 2009) 
 
 
Demographics and socioeconomic levels 
 
 Research has also focused on the contribution of demographic factors to the 
higher values of A1C in minority groups. According to Maruther et al. (2011), elevated 
A1C are a greater reflection of health disparities among different socioeconomic groups.  
This research suggests that environmental and social factors may ultimately lead to 
lifestyle choices within in racial and ethnic groups that are correlated to higher glucose 
concentrations.  Several studies further correlated A1C to that of personal demographics, 
such as body mass index, triglycerides, alcohol use, education, and family history of the 
disease (Dagogo-Jack, 2010; Selvin, Steffes & Zhu, 2009).  These studies concluded that 
genetic and medical conditions partially contribute to the higher A1C, but socioeconomic 
difference and lifestyle choices ultimately explain the variance in A1C.  However, 
variables, such as vitamin D deficiency and certain hemoglobinopathies were not fully 
addressed in this research, could reduce the influence of socioeconomics and lifestyle 
choices on A1C. 
 
 
Infection 
  
 Evidence suggests infection can be a cause shifts in glycemic control.  The body’s 
response to physical or emotional stress during infection can lower the secretion of 
insulin in the system or increase insulin resistance (Jones, Brashers & Huether, 2010).  
During times of infection, individuals are more likely to see higher glucose 
concentrations.  Transient states of higher glycemic levels may occur during infection, as 
the metabolic system is impacted by the infection and subsequent reactions.  
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Hormones 
 
 Hormones have a known influence on glycemic control.  Glucagon, a counter 
regulatory hormone, directly impacts insulin and glucose concentrations (Zander et al., 
2002).  In addition, gut hormones, such as incretin, play a role in the absorption of 
glucose through the gastrointestinal system (Holst, 2011).  With regard to youth, puberty 
and hormone shifts have been shown to impact glycemic control and diabetes 
complications.  Growth hormones and insulin-like growth factors impact the composition 
of body adipose, which increase insulin resistance in some individuals (Cho, Craig & 
Donaghue, 2014).  Evidence suggest hormones can either directly impact the ability of 
the body to control insulin secretion or insulin sensitivity, or hormones can cause the 
body to increase adipose tissue, which indirectly impacts glycemic control (Mortensen & 
Hougaard, 1997). 
 
 
Magnesium deficiency 
 
 Evidences suggest lower levels of magnesium are directly correlated to poorer 
glycemic control.  Galli-Tsinopoulo et al. (2014) examined children and adolescents and 
found magnesium levels were significantly correlated to A1C greater than 7.5%, which 
can contribute to more severe complications of diabetes.  Dasgupta, Sarma & Saikia 
(2012) found similar results in an adult population.  Subjects with hypermagnesia and 
type II diabetes had a mean A1C level of 11.9%, whereas subjects with normal 
magnesium levels had a mean A1C of 9.8% (p=0.0016).  Multiple evidence suggest 
magnesium plays a role in the control of glucose for individuals diagnosed with diabetes 
(Kim et al, 2010; Sales & Pedrosa, 2006). 
 
 
Summary of factors affecting A1C 
 
 Research has shown that a variety of factors influence glycemic control and 
subsequent A1C.  Although the impact of the variables differs between T1DM and 
T2DM, the factors invariably impact both diseases.  The progression and severity of the 
disease is also impacted by these factors.  In addition, both modifiable factors, such as 
BMI, vitamin D levels, magnesium levels, and physical activity, and non-modifiable 
factors, such as race/ethnicity, age, family history, infection, hormonal, and autoimmune 
conditions can impact glycemic control.  
 
 
Beta-cell Function and Insulin Sensitivity in Relation to A1C 
 
 β-cell function and insulin sensitivity are key factors in the pathophysiology of 
prediabetes and diabetes development.  Variation in these factors have been noted among 
different racial and ethnic groups, with Hispanic individuals having greater incidences of 
β-cell dysfunction, while African American individuals have greater incidences of insulin 
resistance (Toledo-Corral, Vargas, Goran & Weigensberg, 2012).  Limited research exists 
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that examines the relationship between A1C, β-cell function, and insulin sensitivity in 
children and adolescents.  With the understanding that β-cell function and insulin 
sensitivity vary between racial and ethnic groups, the relationship between these variables 
should be further explored to ascertain their impact on A1C. 
 
 
Methods of beta-cell function and insulin sensitivity measurement 
 
 Insulin sensitivity and β-cell function can be measured by direct and surrogate 
methods.  The gold standard for insulin sensitivity measurement is the euglycemic-
hyperinsulinemic clamp method.  However, the method is a time-consuming and difficult 
test to perform in large scale screenings and with children and adolescents (Schwartz et 
al., 2008).  Surrogate methods have been developed based on fasting insulin, challenged 
insulin, fasting glucose, and challenged glucose concentrations.  β-cell function can be 
measured accurately via the insulinogenic index (IGI), which measures insulin 
concentration at 30 minutes post glucose challenge minus fasting insulin to the glucose 
measures at similar times (Pacini, Tura, Winzer & Kautzky-Willer, 2005).  Other 
surrogate methods are available.  However, a literature review of other methods has 
shown limited research testing the validity and accuracy of their use. 
 
 
Measurement in children and adolescents 
 
 A small number of studies have examined the accuracy of surrogate measurement 
tools for the measurement of insulin sensitivity and β-cell function in children and 
adolescents.  A cohort study of 31 children found a high correlation between the QUICKI 
(r=0.69) when compared to the eugylcemic-hyperinsulinemic clamp method (Gungor, 
Saad, Janosky & Arslanian, 2004).  Another cohort of 131 children found correlations 
between fasting insulin, QUICKI and HOMA for Caucasians (r=0.91)  and African 
Americans (r=0.86) when compared collectively to the eugylcemic-hyperinsulinemic 
clamp method (Conwell, Trost, Brown & Batch, 2004).  Schwartz et al. (2008) concluded 
that surrogate methods correlate strongly (HOMA, r=0.99; QUICKI, r=0.79) when 
compare to the eugylcemic-hyperinsulinemic clamp method. 
 
 It is unclear why variation exists between these studies.  However, differences 
exist with regard to the demographics of each study sample.  Age, race/ethnicity, and 
sample size were not consistent.  A research gap exists that fully examines the differences 
between racial/ethnic groups and age groups (prepubescent versus pubescent) children 
and adolescents. 
 
 
A1C correlation to insulin sensitivity and beta-cell function 
 
 Insulin sensitivity plays a role in the development of prediabetes and diabetes, in 
addition to other disorders within the spectrum of metabolic syndrome. However, the role 
of insulin sensitivity has not been fully explained.  Research shows insulin sensitivity is 
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lower among African Americans when compared to Caucasian or Hispanic counterparts 
(Bennett et al, 2013).  Insulin sensitivity has also been shown to be correlated to the 
development of metabolic syndrome and cardiovascular diseases (Davis et al., 2012) 
 
 Measurements of insulin sensitivity have shown correlation to A1C (Heiana et al., 
2012).  However, there is a stronger correlation between A1C and β-cell dysfunction than 
insulin sensitivity measurement indices (Hanson et al., 2000).  Kim et al. (2012) also 
A1C were highly associated with insulin secretion/beta-cell function in a group of Korean 
adults (N=616, p=0.001).  Marini et al. (2011) further found a correlation between higher 
A1C and beta cell dysfunction, but also identified moderate correlation between A1C and 
insulin sensitivity in a sample of Italian adults.  Future research is needed to determine 
the degree of correlation among different racial and ethnic groups.   
 
 The pathophysiology of the development of prediabetes and diabetes could 
explain this difference.  Insulin sensitivity often decreases first in the progression of  
T2DM.  A worsening of glycemic control would occur when β-cell function fails to 
compensate for the decrease in insulin sensitivity.  An increase in A1C would most likely 
be seen when β-cell function is not able to counter balance the increase in glucose in the 
system.  The simple pathophysiology of the disease progression could explain the 
stronger correlation between A1C and β-cell dysfunction. 
 
 
Summary 
 
 Research has shown the benefits and shortcomings of utilizing the A1C test for 
the diagnosis of diabetes in adults.  Little evidence exists supporting the use of A1C of 
the screening of prediabetes in children or adolescents.  However, the utilization of A1C 
testing for screening purposes has shown promise.  Factors have been found to affect 
A1C, most noticeably racial and ethnic groups have been found to have higher A1C on 
average, despite having statistically similar 2-hour post prandial glucose concentrations 
(Herman et al., 2009).   
 
 Little research exists that supports the use of A1C testing in children or 
adolescents for the diagnosis or screening of diabetes or prediabetes.  As the criteria for 
the use of A1C testing has been limited to adult populations, research should be 
performed on younger populations to properly extrapolate diagnostic criteria.  Potential 
covariate factors, such as BMI, age, race/ethnicity, and vitamin D levels, should be 
considered and properly evaluated for when considering the use of A1C for the 
diagnosing of diabetes and prediabetes in youth.  
 
 Research has also pointed to a stronger correlation between A1C and beta cell 
dysfunction, when compared to the correlation between A1C and insulin sensitivity.  The 
strength of this relationship is due to the pathophysiology of the disease progress and the 
ability of the body to regulate insulin sensitivity until beta cell dysfunction occurs.  
However, a gap exists in the research that fully explains the strength of the collaboration 
between beta cell dysfunction and insulin sensitivity to A1C in children and adolescents.  
 19 
CHAPTER 3.    HEMOGLOBIN A1C TESTING VERSUS OGTT IN A SAMPLE 
OF AT-RISK CHILDREN AND ADOLESCENTS:  A COMPARISON STUDY 
 
 
Introduction 
 
  The prevalence of diabetes and prediabetes in children and adolescents in the US 
is growing exponentially (CDC, 2013).  The increased number of younger Americans 
with the disease is burdening the health care system.  Children and adolescents with 
diabetes and prediabetes are more prone to develop co-morbidities as they age, such as 
cardiovascular disease, atherosclerosis, kidney disease, and retinopathies (Cho, Craig & 
Donaghue, 2014).  Early identification and subsequent treatment of diabetes and 
prediabetes is imperative. 
 
The ADA recommends the screening of type 2 diabetes in asymptomatic 
adolescents if a body mass index (BMI) is greater or equal to 85% and the adolescent has 
2 or more risk factors for the disease.  Risk factors can include family history, at-risk 
racial/ethnic group, conditions or signs of insulin resistance, small for gestational age at 
birth, or maternal history of gestational diabetes.  The ADA further recommends 
screening tests to be limited to FPG, due to cost and convenience (ADA, 2014).  The 
International Diabetes Federation has yet to endorse the use of A1C testing for 
adolescents or children, although it has endorsed its use for adults (Nowicka at al., 2011).  
As most research regarding use of A1C for diagnosis or screening has been carried out in 
adults, a gap exists concerning the predictive ability of the test in children and 
adolescents. 
 
 The American Diabetes Association (ADA) recommends the A1C test as a 
method of diagnosing diabetes and prediabetes in adults (ADA, 2014). Although research 
supports the diagnostic accuracy of the A1C test when A1C exceed 6.5%, individuals 
with impaired and normal glucose tolerance are often misdiagnosed with this test (ADA, 
2007; Rohfing, et al., 2002). In addition, A1C results have been shown to vary between 
ethnic and racial minority groups, with significantly higher A1C observed in Hispanics 
and African Americans, even after accounting for covariates (Boltri, et al., 2005; Cowie 
et al., 2010; McCarter, Hempe & Chalew, 2006; Wang et al., 2011). As a result, the use 
of the A1C test to identify individuals with diabetes or prediabetes has been not been 
used consistently by clinicians. 
 
The International Expert Committee, appointed by the ADA and the European 
Association for the Study of Diabetes, concluded that the A1C test can effectively 
identify adult individuals at lower risk for developing diabetes (ADA, 2009). However, 
the committee warned of limitations of the test, including inconsistent correlations 
between A1C and fasting glucose results and concerns about the cost and availability of 
the test. The committee found that the A1C test does not accurately diagnose diabetes 
compared to other tests, such as the FPG or OGTT (ADA, 2009). The use of Alc alone to 
diagnose individuals with diabetes or prediabetes must be translated to meaningful 
clinical practice.   
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 To determine the accuracy of the A1C test to diagnose diabetes and prediabetes in 
a sample of children and adolescents identified as at-risk for diabetes and prediabetes, we 
analyzed data from a sample of children and adolescents seeking care for diabetes and 
prediabetes testing at an urban endocrinology clinic in the southeastern United States. 
 
 
Research Design and Methods 
 
 A retrospective review of 904 patient electronic medical records in an urban 
endocrinology clinic was conducted.  Two subjects were excluded due to self-
identification of multiple races/ethnicities.  The A1C, FPG, and OGTT were obtained on 
the same day using a standardized protocol and central laboratory. Demographic data 
(age, gender, and race/ethnicity) and A1C, FPG, and OGTT results were retrieved.   
 
 The study sample consisted of children and adolescents under the age of 18, who 
sought care at a single clinic in the southeastern United States.  Results from blood 
analysis, physical examination, and health history were extracted from a database and 
medical records.  Exclusion criteria include self-report of race/ethnicity other than 
African America, Caucasian, or Hispanic or the self-reporting of multiple racial/ethnic 
groups. 
 
 The current study was approved by the Institutional Review Board of the 
University of Tennessee Health Science Center.  A waiver of consent was obtained and 
no consent or assent for participation was required from the parents/guardian or patient.  
A standardized protocol for data collection was used.  After an 8-10 hour fast, patients 
had an intravenous catheter placed for blood draws.  Fasting blood samples were drawn 
for glucose, insulin and A1C.  Patients consumed 1.75 grams of dextrose/kilogram of 
body weight (up to 75 grams).  Blood samples were obtained at 30, 60, 90, and 120 
minutes during the OGTT for glucose and insulin levels.  
 
 All lab analyses were performed by LabCorp. Plasma glucose was measured 
using an automated glucose oxidase method enzymatic method. Serum immunoreactive 
insulin (µU/ml ) was measured by double-antibody radioimmunoassay. A1C was 
measured using the Roche "Tina-quant" 2nd generation assay which is based 
on turbidimetric inhibition immunoassay (TINA) of hemolyzed whole blood samples.  
 
 
Definitions 
 
 Diabetes and prediabetes were defined based on the 2014 ADA criteria. Diabetes 
was diagnosed if FPG  was > 126 mg/dl or 2-hour OGTT glucose level was > 200 mg/dl.  
Prediabetes was diagnosed if the FPG was 100-125 mg/dl or the 2-hour OGTT glucose 
level was 140-199 mg/dl.  A1C were calculated from the first serum glucose draw on the 
date of visit.  Based on the 2014 ADA criteria, a patient was identified as testing positive 
for diabetes if the A1C was ≥ 6.5% and testing positive for prediabetes if the A1C was 
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5.7-6.4%.  FPG levels were drawn from serum samples following 8-10 hours of patient or 
parent/guardian self-reported fasting.  Based on the 2014 ADA, a patient was diagnosed 
with diabetes in the FPG was ≥126mg/dl or diagnosed with prediabetes if the FPG was 
100-125 mg/dl. 
 
 
Statistical analysis 
 
      We analyzed the role of A1C is the diagnosis of diabetes and prediabetes by use 
of sensitivity, specificity, positive predictive value, negative predictive value for the 
overall sample.  Analyses were made by race and ethnicity (African American, Hispanic, 
and Caucasian) and by designated age groups (0-5 years, 6-11 years, and 12-18 years), if 
possible.  The sensitivity, specificity, positive predictive value, and negative predictive 
value of the A1C diagnostic values for diabetes (A1C≥6.5%) and prediabetes (A1C 5.7–
6.4%) were calculated using SAS version 9.2.   
 
 We compared the predictive ability of the A1C to the FPG and OGTT as 
continuous variables using Receiver operator characteristic curve (ROC) analysis (1-
specificity).  The Delong, Delong, Clarke-Pearson (1988) methods was used to determine 
the criterion diagnostic threshold values for diabetes and prediabetes via MedCalc 
version 12.7.  The thresholds were determined by optimal points where sensitivity and 
specificity were maximized (95% CI). 
 
 
Results 
 
 Test results from 902 subjects were analyzed.  Two individuals were eliminated 
after self-identifying as more than one racial/ethnic group.  The sample was 
predominately African American (70.7%) and female (60.7%).  In addition, the BMI of 
the sample was 33.4 ± 8.12.  The average age of the sample was 11.6 ± 3.32 years.  
Table 3-1 summarizes sample characteristics stratified by race/ethnicity and gender. 
 
 The prevalence of diabetes based on the OGTT was 1.7% (n=15), whereas the 
prevalence of diabetes based on A1C values was 2.9% (n=26).  The prevalence of 
prediabetes based on the OGTT was 5.6% (n=51), whereas the prevalence of prediabetes 
based on A1C values was 54.3% (n=491).  Mean A1C was 5.7 ± 0.5% for the 902 
subjects. 
 
 
A1C and diabetes prediction by race and ethnicity 
 
 A1C accurately predicted disease in children and adolescents diagnosed with 
diabetes via an OGTT.  As noted in Table 3-2, sensitivity of the A1C test to OGTT was 
90.9% for the sample, while specificity was higher at 99.7%. Whereas, positive 
predictive value was 87.0% and negative predictive values was 99.9% for the sample. 
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Table 3-1. Sample characteristics:  Total and by race and ethnicity 
 
Characteristic Total African 
American 
Caucasian Hispanic 
Ethnicity (N,%)  902 (NA) 639 (70.7) 109 (12.0) 154 (17.3) 
Male (N,%) 355 (39.3) 249 (38.0) 35 (32.1) 70 (45.5) 
Female (N,%) 547 (60.7) 390 (61.0) 74 (67.9) 84 (54.5) 
Age (mean±SD) 11.6 ±3.32 11.8 ±3.2 12.2 ±3.2 10.3 ±3.5*^ 
Diabetes-OGTT* (N,%) 15 (1.7) 13 (2.0) 0 (0) 2 (1.3) 
Diabetes-A1C* (N,%) 26 (2.9) 23 (3.5) 2 (1.8) 1 (0.6) 
Prediabetes-OGTT* (N,%) 51 (5.6) 39 (6.1) 7 (6.4) 5 (3.2) 
Prediabetes-A1C* (N,%) 491 (54.3) 401 (62.8) 34 (31.2) 56 (35.9) 
A1C (mean±SD) 5.7 ±0.5 5.8 ±0.5 5.6 ±0.3* 5.6 ±0.3* 
*Based on 2014 ADA Standards of Medical Care.  Diabetes diagnosis with OGTT 2 hr 
results ≥200 mg/dl or OGTT fasting ≥ 120mg/dl or A1C ≥6.5%.  Prediabetes diagnosis 
with OGTT 2 hr results 140-199 mg/dl or OGTT fasting ≥ 100-125mg/dl or A1C 5.7-
6.4%.  *p≤0.05 between African American and group with like symbol.  ^ p≤0.05 between 
Caucasian and group with like symbol. 
 
 
 
Table 3-2.   Summary of results by race and ethnicity 
 
Condition 
Group Screened 
Sensitivity 
% 
Specificity 
% 
PPV 
% 
NPV 
% 
Diabetes* 90.9 99.7 87.0 99.9 
African American 91.0 99.4 76.9 99.8 
Caucasian 100 100 100 100 
Hispanic 100 100 100 100 
Pre-Diabetes* 82.7 44.7 8.6 97.9 
African American 92.1 35.9 8.6 98.6 
Caucasian 
Hispanic 
71.4 
50.0 
69.6 
63.2 
13.9 
3.6 
97.2 
97.8 
*Based on 2014 ADA Standards of Medical Care.  Diabetes diagnosis with OGTT 2 hr 
results ≥200 mg/dl or OGTT fasting ≥ 120mg/dl or A1C ≥6.5%.  Prediabetes diagnosis 
with OGTT 2 hr results 140-199 mg/dl or OGTT fasting ≥ 100-125mg/dl or A1C 5.7-
6.4%.   
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 The A1C was not able to accurately predict prediabetes compared to an oral 
glucose tolerance test.  Sensitivity and negative predictive values were high, 82.7% and 
97.9% respectively.  However, specificity and positive predictive value for the sample 
were low, 44.7% and 8.6% respectively. 
 
 When stratified by race, A1C had lower sensitivity, specificity, positive predictive 
value, and negative predictive value for diagnosing diabetes in African Americans 
compared to Hispanic and Caucasian counterparts.  As noted in table 3-2, Hispanic and 
Caucasian subjects had 100% sensitivity, specificity, positive predictive value, and 
negative predictive value when using A1C to diagnose diabetes compared to OGTT.  
However, these results were skewed by the limited number of diabetes positive via 
OGTT subjects in these groups (n=2). 
 
 Hispanic subjects had lower sensitivity (50.0%) than African Americans (92.1%) 
and Caucasians (71.4%) when diagnosing prediabetes via A1C; whereas, African 
Americans subjects had decreased specificity for prediabetes (35.9%) when compared to 
their counterparts.  Positive predictive values were low for all groups, however, markedly 
lower for African Americans (8.6%) and Hispanic (3.6%) subjects.  Negative predictive 
value for prediabetes diagnosis was higher for African Americans (98.6%) and Hispanic 
(97.2%) subjects than Caucasian (97.8%) subjects. 
 
 
ROC curves 
 
 ROC curve analyses were performed for the sample and were stratified based on 
race/ethnicity and age groups.  The ROC curve analysis was performed on the overall 
sample to determine a diabetes criterion threshold, but the analysis was not stratified due 
to limited positive cases in each racial/ethnic group and age group.  ROC curves were 
also not performed for prediabetes cases on subjects under the age of 12, due to limited 
positive cases.  A summary of all ROC curve analysis results is found in Table 3-3. 
 
 ROC curve analysis of the aggregate sample determined the criterion threshold 
for diabetes diagnosis is an A1C level greater than 5.8% (Figure 3-1).  The area under 
the curve was 0.763 with a Youden Index 0.4196.  This threshold is significantly lower 
than the 6.5% A1C as recommended by the ADA.  
 
 Figure 3-2 shows the A1C criterion threshold for prediabetes diagnosis is greater 
than 5.6%.  The area under the curve is 0.705, with a Youden Index of 0.312.  Figures  
3-3, 3-4, and 3-5 show the stratified ROC curve analyses based on race and ethnicity.  
The African American group has a significantly higher A1C criterion threshold of 5.8%, 
while the Caucasian and Hispanic groups had lower criterion of 5.5%. 
 
 Figure 3-6 shows the ROC curve analysis for prediabetes in subjects 12-18 years 
of age. The A1C threshold criterion in this group is 5.7%.  These findings are also 
consistent with the ADA recommended guidelines for the diagnosis of prediabetes in  
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Table 3-3. Summary of ROC curve analysis 
 
Disease/Group Threshold 
Criterion 
AUC 95% CI Youden Index 
Diabetes     
All >5.8% 0.763 0.734-0.791 0.4196 
Prediabetes     
All >5.6% 0.705 0.674-0.735 0.3120 
African   American >5.8% 0.703 0.665-0.738 0.319 
Caucasian >5.5% 0.807 0.721-0.877 0.4552 
Hispanic >5.5% 0.543 0.460-0.625 0.2685 
12-18 years >5.7% 0.703 0.665-0.738 0.3190 
Summary based on DeLong, Delong, Clarke-Pearson method. See Delong, E.R., Delong, 
D.M., & Clarke-Pearson, D.L. (1988). Comparing the area under two or more correlated 
receiver operating characteristic curves: A nonparametric approach. Biometrics, 44(3), 
837-845. 
 
 
 
 
 
Figure 3-1. ROC curve analysis of diabetes criterion threshold for all subjects 
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Figure 3-2. ROC curve analysis of prediabetes criterion threshold for all subjects 
 
 
 
 
 
Figure 3-3. ROC curve analysis of prediabetes criterion threshold for African 
American group 
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Figure 3-4. ROC curve analysis of prediabetes criterion threshold for Caucasian 
group. 
 
 
 
 
 
Figure 3-5. ROC curve analysis of prediabetes criterion threshold for Hispanic 
group 
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Figure 3-6. ROC curve analysis of prediabetes criterion threshold for subjects age 
12-18 years 
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adults, but is higher than the A1C criterion threshold of the overall sample (5.6%) (ADA, 
2014). 
 
 
Discussion 
 
 The A1C test held a high level of specificity and negative predictive value for all 
ages and race/ethnic groups when testing for diabetes, which indicates the test can 
successfully identify high-risk individuals without disease.  In addition, the specificity 
and positive predictive value of all groups was high, which indicates some success when 
identifying high-risk individuals with the disease using the A1C alone.   
 
 More caution should be displayed when using the A1C to diagnose prediabetes in 
all groups.  Although the test had a high sensitivity and negative predictive value (82.7% 
and 97.9%), it showed lower specificity and positive predictive value (44.7% and 8.6%) 
in successfully diagnosing prediabetes.  The A1C test appears to more accurately identify 
high-risk individuals who does not have prediabetes, but may over diagnose children and 
adolescents with prediabetes if used alone.  
 
 In high-risk children and adolescents in a nonfasting state, the A1C test could be 
used as a screening device to identify individuals needing OGTT.  Current 
recommendations by the ADA call for diabetes testing of asymptomatic adolescents if 
BMI is greater or equal to 85th percentile, and the adolescent has 2 or more risk factors 
for the disease.  However, the testing is limited to FPG due to cost and time constraints.  
The A1C could be used as alternate screening test for children and adolescents to identify 
individuals needing the more invasive OGTT.   
 
 Given that many children with lower BMI levels are now testing positive for 
prediabetes and diabetes (CDC, 2013), the test could be expanded to children with BMI 
levels below 85% or with no symptoms.  The A1C test could be used as a screening test 
annually for children and adolescents deemed at high-risk for disease development.  
Since the test requires no fasting and can be performed with a venous puncture, the use of 
the A1C test could be used to screen successfully all children and adolescents for the 
diseases.  In addition, the A1C could be used to screen children and adolescents with one 
or more risk factor for diabetes or prediabetes. 
 
 Criterion thresholds for each race and ethnic group and age group of similar 
characteristics should be considered.  African American children and adolescents should 
use a threshold of 5.8% for prediabetes screening purposes, whereas Caucasian and 
Hispanics children and adolescents should use a lower threshold (5.6-5.7%).  For African 
American children and adolescents, the use of lower criterion thresholds may results in 
later stage diagnoses, which delays the initiation of preventative measures.  Clinicians 
should take into account that adolescents overall A1C followed thresholds similar to 
ADA recommendations for adults.  However risk factors and race/ethnicity should be 
considered at all times when using the A1C as a screening tool.  The study noted only 8 
false negatives for prediabetes diagnosis in the sample, and none for diabetes diagnosis.  
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Clinicians should consider the use of serial A1C testing or OGTT in children with 
multiple risk factors for prediabetes or diabetes. 
 
 Performing OGTT on high-risk children and adolescents after positive A1C 
testing, rather than based solely on risk factors, could provide a cost savings to the health 
care consumer.  This study showed the A1C could accurately identify children or 
adolescents at low-risk for prediabetes.  Using the A1C and risk factors as a screening 
tool for the more costly and time consuming OGTT, could save the consumer in cost, in 
addition time and resources. 
 
 Limitations of the study include the small number of subjects testing positive for 
diabetes.  The subjects were referred to the clinic often following previous office visits 
with primary care providers.  The majority of cases of diabetes were found via FPG on 
previous visits.  A higher number of diabetes positive subjects were needed to carry out 
ROC curve analysis on all age groups to determine A1C optimal cut-off points for 
diabetes.  In addition, the BMI of the sample was not representative of the population.  
The average BMI was 33.41 ± 8.12.  The sample consisted mainly of overweight and 
obese children and adolescents.  The study needs to be replicated with children and 
adolescents across the BMI spectrum to validate results. 
 
 The study also applied only to diagnostic testing by OGTT (either the FPG or 2 hr 
value).  Many clinicians use the FPG alone when screening children and adolescents for 
diabetes or prediabetes.  Research has shown the FPG is not reflective of postload 
glucose concentrations (Monnie et al., 2003).  Comparing the A1C to the FPG alone 
could reflect differences in screening abilities.  A prospective study is needed to compare 
the use of A1C to FPG testing. 
 
 Similar to other studies (Nowicka et al., 2011; Lee et al. 2011) our results support 
the need for A1C specific thresholds for determination of prediabetes.  In our multi-
ethnic sample of predominantly overweight and obese youth, the ADA guidelines of A1C 
> 6.5% for the diagnosis of diabetes underestimated diabetes. Using ROC analyses, the 
optimal A1C threshold to identify diabetes in our sample was 5.8%. These findings are 
consistent with results reported by Nowicka et al. (2011) showing that 5.8% was the 
optimal A1C threshold to identify type 2 diabetes in multi-ethnic cohort of obese children 
and adolescents.    
 
 Similarly, Lee et al. (2011) found low sensitivity (75%) but high specificity 
(>99%) when using A1C for diagnosing diabetes and prediabetes in adolescents 
compared to FPG.  Utilizing NHANES data for individuals between 12-19 years of age 
and an adult sample   the ability of A1C to predict prediabetes based on ROC curve 
analysis was low (ROC:  AUC:  0.61 diagnosis based on FPG and AUC:  0.53 diagnosis 
based on 2 hr OGTT).  The lower prevalence of diabetes and prediabetes in the childhood 
and adolescent population make it difficult to correlate A1C adult criteria to other 
populations. While A1C values may be useful in screening children and adolescents, 
applying adult criteria to younger populations greatly underestimated the cases of 
diabetes and prediabetes.   
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 The use of A1C as a diagnostic or screening tool for children or adolescents 
requires further testing and validation to effectively identify optimal levels.  However, the 
cost and ease of administering the test compared to the OGTT, could provide an alternate 
means of diagnosing prediabetes or diabetes in younger populations.  In addition, the 
prior research has shown the A1C is superior in diagnostic and screening value compared 
to the FPG, which is commonly used by clinicians. 
 
 In summary, the A1C can be successfully used to screen for prediabetes or 
diabetes in a population with risk factors for the disease.  Additional testing is needed to 
establish optimal threshold values for children and adolescents with normal BMI and no 
risk factors.  In addition, care should be used when evaluating current recommended 
optimal criterion thresholds, as racial/ethnic differences are noted.  
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CHAPTER 4.    FACTORS AFFECTING HEMOGLOBIN A1C IN THE 
DIAGNOSIS OF DIABETES AND PREDIABETES IN CHILDREN AND 
ADOLESCENTS 
 
 
Introduction 
 
 The American Diabetes Association currently recommends screening for type 2 
diabetes in asymptomatic adolescents, if their BMI is greater or equal to the 85% 
percentile, and the adolescent has 2 or more risk factors for the disease.  Risk factors can 
include family history, at-risk racial/ethnic group, conditions or signs of insulin 
resistance, small for gestational age at birth, or maternal history of gestational diabetes.  
The ADA further recommends screening tests be limited to FPG, due to cost and 
convenience (ADA, 2013).  The International Diabetes Federation has yet to endorse the 
use of A1C testing for adolescents or children, although it has endorsed its use for adults 
(Nowicka at al., 2011).   There is a paucity of research regarding the clinical utility of 
A1C to predict diabetes and prediabetes in children and adolescents. 
 
 The correlation between plasma glucose and A1C also has been shown to differ 
between adults and youth.  Ogawa et al. (2012) examined school-aged children in Japan 
(N=298) and found FPG levels were not as highly correlated to A1C, when compared to 
adult counterparts.  Seino et al. (2010) found similar results in school-age children group, 
with an A1C of 6.5% correlated to a FPG=111.4 mg/dL, Similar research shows 
standardized scales correlating A1C to plasma glucose concentrations should be 
reanalyzed for children and adolescents.   
 
 Research has yet to consistently examine the effects of various factors on A1C in 
children and adolescence.  As noted in Figure 1-1, a variety of factors influence glycemic 
control and subsequently A1C.  This study will examine BMI, race/ethnicity, age, gender, 
insulin sensitivity, β-cell function to determine their influence on A1C.  While it is 
widely accepted that beta cell dysfunction is a known contributor to increased A1C, the 
contribution of various factors to the A1C in children and adolescents has not been fully 
explored.  
 
 
Racial and ethnic factors 
 
 Racial and ethnic groups show statistically significant mean differences and 
variation in A1C (Herman, et al., 2007; Herman et al., 2009; Kirk, et al., 2008). Studies 
have shown variations in A1C among different racial groups, whereas mean plasma 
glucose concentrations do not vary between racial groups.  These results suggest a 
biological basis for the variability across racial groups with respect to A1C testing 
(Bonds, et al., 2003; Christensen, et al., 2010; Cohen, 2007).  
 
 Kirk et al. (2005) concluded that the differences between racial and ethnic groups 
were consistent across previous research studies, after adjusting for covariates.  Herman 
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et al. (2007) also compared A1C from 5 different racial and ethnic groups.  Using an 
adult sample (N=3,819), the study found A1C were higher in racial and ethnic minority 
after adjusting for other covariates. The difference was particularly high among African 
American and Hispanic subjects.  Herman et al. (2007) concluded caution should be 
taken when using A1C to diagnose diabetes in certain minority groups. 
 
 Herman et al. (2009) further examined the racial and ethnic difference in A1C 
when compared to mean plasma glucose concentrations.  Using a multicenter sample in 
11 countries (N=2094), the study found difference between racial and ethnic groups for 
A1C and 1,5-anhdroglucitol levels, but not for mean plasma glucose concentrations.  The 
research suggests criteria established for the diagnosis of diabetes based on A1C might be 
challenging due to inherent differences between racial and ethnic groups (Herman et al., 
2009). 
 
 
BMI and lifestyle 
 
 Research has supported the concept that multiple metabolic, physiological, and 
lifestyle factors exist that influence serum glucose and A1C (Maruther et al., 2011).  
Research also has identified factors that explain the difference in A1C between racial and 
ethnic groups that include lifestyle choices and health disparities (Maruther et al., 2011).  
Most research focuses on lifestyle choices, such as diet and exercise, and their impact on 
glucose concentrations. Obesity is a known risk factor for the development of diabetes 
and prediabetes in children and adolescents, as a positive correlation is seen between 
BMI and the presence of the disease (ADA, 2014).  However, little research has focused 
on the effects of diet and exercise directly on the A1C.  
 
 
Age 
 
 Little research exists that examines factors influencing A1C in children or 
adolescents.  Cho, Craig & Donoghue (2014) determined puberty marked a significant 
shift in glycemic control and diabetes complications.  As the start of puberty varies 
between individuals, it is difficult to ascertain when puberty and age begin to affect 
glycemic control for an individual.  Mortenson & Hougaard also noted that individuals 
with earlier onsets of puberty have an increased risk for developing prediabetes or 
diabetes.  As the onset of puberty grows increasingly earlier, due to diet and activity 
levels, age should be evaluated as a possible proxy to the onset of puberty and the 
possible risk of disease development.  
 
 
Vitamin D deficiency 
 
 Recent research has focused on the role of Vitamin D in diabetes (Takiishi et al., 
2010).  Vitamin D deficiency has a suspected in role in the development of type 1 
diabetes and in the functional ability of beta cells in type 2 diabetes (Zitterman, Alberti & 
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Shaw, 2001).  According to Yiu et al. (2011), there is a significant correlation between 
vitamin D deficiency and A1C.  A prospective study by Forouhi et al. (2008) reported an 
inverse relationship between vitamin D levels and future insulin resistance.  Baseline 
vitamin D insufficiency was correlated a 10 year risk of increased fasting glucose 
concentrations, 2 hour-glucose concentrations, and a metabolic syndrome risk factor 
score.   
 
A recent prospective study focusing on newly diagnosed youth also reported 
similar results.  Doga et al. (2014) reported 91.9% of newly diagnosed youth (n=72) had 
vitamin D deficiency, whereas only 58.5% of non-diagnosed individuals in the control 
group (n=42) had vitamin D deficiency (p value=0.01).  Bayani et al. (2013) validated 
previous research when it reported similar findings between a group of matched diabetes 
cases and non-diseased subjects.  The mean concentration of vitamin D in the case group 
was 18.7 ± 10.2 ng/dl, whereas the mean concentration in the control group was 24.6 ± 
13.5 ng/dl (p=0.002).   
 
NHANES data indicate vitamin D deficiency in the southern United States is 
estimated to be 53-76% for non-Hispanic blacks compared to 8-33% for non-Hispanic 
whites (Looker, et al. 2002).  With multiple studies indicating a connection between A1C 
and vitamin D deficiency, in addition to the knowledge that African Americans often 
suffer greater rates of vitamin D deficiencies, a connection could exist between lower 
vitamin D levels and higher A1C in African Americans. 
 
 
Beta-cell function and insulin sensitivity in relation to A1C 
 
 β-cell function and insulin sensitivity are key factors in the pathophysiology of 
prediabetes and diabetes development.  Variation in these factors have been noted among 
different racial and ethnic groups, with Hispanic individuals having greater incidences of 
β-cell dysfunction, while African American individuals have greater incidences of insulin 
resistance (Toledo-Corral, Vargas, Goran & Weigensberg, 2012).  Limited research exists 
that examines the relationship between A1C, β-cell function, and insulin sensitivity in 
children and adolescents.  With the understanding that β-cell function and insulin 
sensitivity vary between racial and ethnic groups, the relationship between these variables 
should be further explored to ascertain their impact on A1C. 
 
 Insulin sensitivity and β-cell function can be measured by direct and surrogate 
methods.  The gold standard for insulin sensitivity measurement is the euglycemic-
hyperinsulinemic clamp method.  However, the method is a time-consuming and difficult 
test to perform in large scale screenings and with children and adolescents (Schwartz et 
al., 2008).  Surrogate methods have been developed based on fasting insulin, challenged 
insulin, fasting glucose, and challenged glucose concentrations.  β-cell function can be 
measured accurately via the insulinogenic index (IGI), which measures insulin 
concentration at 30 minutes post glucose challenge minus fasting insulin to the glucose 
measures at similar times (Pacini, Tura, Winzer & Kautzky-Willer, 2005).  Other 
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surrogate methods are available.  However, a literature review of other methods has 
shown limited research testing the validity and accuracy of their use. 
 
 
Measurement in children and adolescents 
 
 A small number of studies have examined the accuracy of surrogate measurement 
tools for the measurement of insulin sensitivity and β-cell function in children and 
adolescents.  A cohort study of 31 children found a high correlation between the QUICKI 
(r=0.69) when compared to the eugylcemic-hyperinsulinemic clamp method (Gungor, 
Saad, Janosky & Arslanian, 2004).  Another cohort of 131 children found correlations 
between fasting insulin, QUICKI and HOMA for Caucasians (r=0.91) and African 
Americans (r=0.86) when compared collectively to the eugylcemic-hyperinsulinemic 
clamp method (Conwell, Trost, Brown & Batch, 2004).  Schwartz et al. (2008) concluded 
that surrogate methods correlate strongly (HOMA, r=0.99; QUICKI, r=0.79) when 
compare to the eugylcemic-hyperinsulinemic clamp method. 
 
 It is unclear why variation exists between these studies.  However, differences 
exist with regard to the demographics of each study sample.  Age, race/ethnicity, and 
sample size were not consistent.  A research gap exists that fully discusses the differences 
between racial/ethnic groups and age groups (prepubescent versus pubescent) children 
and adolescents. 
 
 
A1C correlation to insulin sensitivity and beta-cell function 
 
 Insulin sensitivity plays a role in the development of prediabetes and diabetes, in 
addition to other disorders within the spectrum of metabolic syndrome. However, the role 
of insulin sensitivity has not been fully explained.  Research shows insulin sensitivity is 
lower among African Americans when compared to Caucasian or Hispanic counterparts 
(Bennett et al, 2013).  Insulin sensitivity has also been shown to be correlated to the 
development of metabolic syndrome and cardiovascular diseases (Davis, McGraw, 
Garner, 2012) 
 
 Measurements of insulin sensitivity have shown correlation to A1C (Heiana et al., 
2012).  However, there is a stronger correlation between A1C to β-cell dysfunction than 
insulin sensitivity measurement indices (Hanson et al, 2000).  Kim et al. (2012) also A1C 
were highly associated with insulin secretion/beta-cell function in a group of Korean 
adults (N=616, p=0.001).  Marini et al. (2011) further found a correlation between higher 
A1C and beta cell dysfunction, but also identified moderate correlation between A1C and 
insulin sensitivity in a sample of Italian adults.  Future research is needed to determine 
the degree of correlation among different racial and ethnic groups.   
 
 The pathophysiology of the development of prediabetes and diabetes could 
explain this difference.  Insulin sensitivity often decreases first in the progression of the 
disease.  A worsening of glycemic control would occur when β-cell function fails to 
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compensate for the decrease in insulin sensitivity.  An increase in A1C would most likely 
be seen when β-cell function is not able to counter balance the increase in glucose in the 
system.  The simple pathophysiology of the disease progression could explain the 
stronger correlation between A1C and β-cell dysfunction. 
 
 Research has shown the benefits and shortcomings of utilizing the A1C test for 
the diagnosis of diabetes.  However, little evidence exists supporting the use of A1C for 
the screening of prediabetes.  However, the utilization of A1C testing for screening 
purposes has shown promise.  Factors have been found to affect A1C, most noticeably 
racial and ethnic groups have been found to have higher A1C on average, despite having 
statistically similar 2-hour post prandial glucose concentrations (Herman et al., 2009).   
 
 Research has also pointed to a stronger correlation between A1C and beta cell 
dysfunction, when compared to the correlation between A1C and insulin sensitivity.  The 
strength of this relationship could be due to the pathophysiology of the disease progress 
and the ability of the body to regulate insulin sensitivity until beta cell dysfunction 
occurs.  A gap in research ultimately exists that fully explores the relationship between 
beta cell dysfunction and insulin sensitivity to A1C in children and adolescence. 
 
 
Research Design and Methods 
 
 A retrospective review of 904 patient electronic medical records in an urban 
endocrinology clinic was conducted.  Two patients were excluded after self-identifying 
multiple racial/ethnic groups, which resulted in a sample size of 902.  The A1C, FPG, 
OGTT, and insulin levels were obtained on the same day using a standardized protocol 
and central laboratory. Demographic data (age, gender, and race/ethnicity) and A1C, 
FPG, OGTT, and insulin level results were retrieved.  Family history and BMI were also 
retrieved from medical records.   
 
 The study sample consisted of children and adolescents under the age of 18 (2-
18yrs) who sought diagnostic testing and care at a single clinic in the southeastern United 
States.  Subjects were referred for additional testing and care due to one or more risk 
factor for the development of diabetes or prediabetes, including increased BMI and 
family history of disease.  Results from blood analysis, physical examination, and health 
history were extracted from a database and medical records.  Exclusion criteria include 
reporting of race/ethnicity other than African America, Caucasian, or Hispanic. 
 
 The current study was approved by the Institutional Review Board of the 
University of Tennessee Health Science Center.  A waiver of consent was obtained and 
no consent or assent for participation was obtained from the parents/guardian or patient.  
A standardized protocol for data collection was used.  After an 8-10 hour fast, patients 
had an intravenous catheter placed for blood draws.  Fasting blood samples were drawn 
for glucose, insulin and A1C.  Patients consumed 1.75 grams of dextrose/kg of body 
weight (up to 75 grams).  Blood samples were obtained at 30, 60, 90, and 120 minutes 
during the OGTT for glucose and insulin levels.  
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 All lab analyses were performed by LabCorp. Plasma glucose was measured 
using an automated glucose oxidase method enzymatic method. Serum immunoreactive 
insulin (µU/ml ) was measured by double-antibody radioimmunoassay. A1C was 
measured using the Roche "Tina-quant" 2nd generation assay which is based 
on turbidimetric inhibition immunoassay (TINA) of hemolyzed whole blood samples. 
Vitamin D was measured via 25-hydroxy vitamin D assay.   
 
We analyzed the relationship between race/ethnic groups (African American, 
Caucasian, Hispanic), gender, age, BMI, vitamin D, fasting glucose, and fasting insulin to 
the A1C.  BMI was calculated the equation for BMI calculation [BMI=((mass in 
pounds)/(height in inches2))x703].  Pearson correlation testing were performed on 
individual variable, with significance set at 0.20 or less.  Variables with p-values less 
than or equal to 0.20 were included in the multiple regression model in a backward 
method.  Variables were included in the final model if significance was determined to be 
less than or equal to 0.05.  The analyses were repeated for the separate racial/ethnic 
groups.  A t-test was performed to determine significant difference between the genders.  
All analyses were performed using SAS version 9.2 (Cary, NC). 
 
A Pearson correlation determined the strength of relationship between A1C and 
insulin sensitivity and beta cell dysfunction.  Fasting insulin (INS0), corrected insulin at 
30 minutes post collection (CIR30), and IGI were used as proxy measurements of insulin 
sensitivity.  Corrected insulin sensitivity index (CISI), QUICKI, and HOMA were used 
as proxy measurements of beta cell function.  Equation indices for the tests are listed in 
Table 4-1.  Significance was set at 0.05.  All analysis was performed using SAS version 
9.2 
 
 De-identified data were stored on a Microsoft Excel spreadsheet. Gender (1,0) 
and race/ethnicity (0, 1, 2) were categorized as discreet variables.  Descriptive statistics 
were used to describe demographic characteristics for the participants.  Means with 
standard deviation were calculated for continuous variables.  Frequency distributions 
were calculated for categorical data.   
 
 
Results 
 
 Test results from 902 subjects were analyzed.  The sample was predominately 
African American (70.7%) and female (60.7%).  In addition, the BMI of the sample was 
33.4 ± 8.12.  The average age of the sample was 11.6 ± 3.32 years.  Table 4-1 
summarizes sample characteristics stratified by race/ethnicity and gender. 
 
 The prevalence of diabetes based on the OGTT was 1.7% (n=15), whereas the 
prevalence of diabetes based on A1C values was 2.9% (n=26).  The prevalence of 
prediabetes based on the OGTT was 5.6% (n=51), whereas the prevalence of prediabetes 
based on A1C values was 54.3% (n=491).  Mean A1C at testing was 5.7 ± 0.5% for the 
902 subjects. 
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Table 4-1. Insulin sensitivity and beta-cell function indices equations 
 
Indices Equation 
CIR30* = I30 x 100 (I30 μU/ml = insulin at 30 minutes, G30 mg/dl = glucose at 30 minutes) 
[G30 x (G30-70)] 
CISI† =                            _______________________10000____________________________                                    
Square Root [(FI x FBG) x (mean insulin (0-120 min) x mean glucose (0-120 min)] 
(FI μU/ml = fasting insulin, FBG mg/dl = fasting blood glucose) 
 
HOMA‡ =1/((FBG mmol X FI μU/ml)/22.5) 
 
IGI* = __I30-FI_    (FI μU/ml = fasting insulin, FBG mg/dl = fasting blood glucose, 
G30-FBG   I30 μU/ml = insulin at 30 minutes, G30 mg/dl = glucose at 30        minutes) 
 
QUICKI§ =(1/log FI μU/ml) + log FBG 
* Sluiter, W.J., Erkelens, D.W., Terpstra, P., Reitsma, W.D., Doorenbos, H. (1976). Glucose tolerance and insulin release, a 
mathematical approach. II. Approximation of the peripheral insulin resistance after oral glucose loading. Diabetes, 25, 245-249. 
† Matsuda, M., DeFronzo, R.A. (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the 
euglycemic insulin clamp. Diabetes Care, 22, 1462-1470. 
‡ Yokoyama, H., Emoto, M., Fujiwara, S. (2003). Quantitative insulin sensitivity check index and the reciprocal index of homeostasis 
model assessment in normal range weight and moderately obese type 2 diabetic patients. Diabetes Care, 26, 2426-2432. 
§ Uwaifo, G.I., Parikh, S.J., Keil, M., Elberg, J., Chin, J., Yanovski, J.A. (2002) Comparison of insulin sensitivity, clearance, and 
secretion estimates using euglycemic and hyperglycemic clamps in children. J Clin Endocrinol Metab, 87, 2899-2905. 
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 As outlined in Table 4-2, a correlation analysis was performed to determine 
which variables to include in the multiple regression model.  Variables with significance 
less than or equal to 0.20 were included.  All race/ethnic groups, gender, BMI, vitamin D 
level, fasting glucose, and fasting insulin were considered significant. 
 
 A multiple regression was then performed.  The model chose a nonzero solution 
for the parameters that were not unique, and a nonzero solution for the variables that were 
linearly independent of previous variables, and a zero solution for other variables.  As a 
result, the African American group was excluded from the model due to the variable not 
being full rank and the least-square solutions for the specific parameters not being unique 
for the group.  The African American group produced biased estimates, and was 
subsequently excluded. 
 
 As outlined in Table 4-3, the significance for the overall regression model was 
established at less than or equal to 0.05. The Hispanic group, Caucasian group, and 
fasting glucose were determined to be significant, although the R-squared value for the 
model itself was only 0.098.  We determined less than 10% of the variation from these 
three variables could account for the variation in the model as designed. 
 
 The data were then stratified between racial and ethnic groups and the multiple 
regressions were repeated.  As outlined in Tables 4-4 and 4-5, gender, fasting glucose, 
and fasting insulin were found to be significant at 0.20 or less for the African American 
group.  A multiple regression model found only fasting insulin and fasting glucose to be 
significant at 0.05 or less.  However, the R-square for the model was 0.053, which shows 
the model explains little variation in the A1C level. 
 
 As outlined in Tables 4-6 and 4-7, age, fasting glucose, and fasting insulin were 
found to be significant at 0.20 or less for the Caucasian group.  A multiple regression 
model found age, fasting insulin and fasting glucose to be significant at 0.05 or less.  The 
R-square value for this model was 0.288.  This model explains significantly more 
variation in the A1C level, than compared to the African American group.  However, the 
inverse association between A1C and age was weak. 
 
As outlined in Tables 4-8 and 4-9, among the Hispanic group, only fasting 
glucose was found to be significant at 0.20 or less.  A simple regression showed the 
fasting glucose to be significant at 0.039 level.  However, the R-square value was only 
0.027, which explains little variation in the A1C. 
 
 Pearson correlation was performed to examine the relationship between insulin 
sensitivity and beta cell function to A1C.  Table 4-10 outlines the results. CIRC30, CISI, 
and QUICKI were significantly negatively correlated, while HOMA was positively 
correlated with the A1C level.  Results indicate A1C is correlated with all beta cell 
function proxy measurements and correlated to the corrected insulin level at 30 minutes, 
but not the fasting insulin or insulinogenic index.   
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Table 4-2. Sample characteristics:  Total and by race and ethnicity 
 
* Based on 2014 ADA Standards of Medical Care.  Diabetes diagnosis with OGTT 2 hr 
results ≥200 mg/dl or OGTT fasting ≥ 120mg/dl or A1C ≥6.5%.  Prediabetes diagnosis 
with OGTT 2 hr results 140-199 mg/dl or OGTT fasting ≥ 100-125mg/dl or A1C 5.7-
6.4%.   
* p≤0.05 between African American and group with like symbol.  
† p≤0.05 between Caucasian and group with like symbol. 
 
 
 
Table 4-3. Pearson correlation for individual variables to A1C in overall sample 
 
Variable Coefficient std Error t p-Value 
African American 0.226 0.330 6.960 0.00* 
Caucasian -0.144 0.470 -4.394 0.00* 
Hispanic -0.147 0.041 -4.451 0.00* 
Gender -0.052 0.032 -1.552 0.12* 
Age -0.010 0.005  -0.287 0.77 
BMI 0.081 0.002 2.431 0.02* 
Vitamin D -0.119 0.002 -3.519 0.00* 
Fasting Glucose 0.231 0.002 7.120 0.00* 
Fasting Insulin 0.043 0.000 1.340 0.20* 
*Variables with significance at <0.20 
 
 
  
Characteristic     Total   African 
American 
Caucasian  Hispanic 
Ethnicity (N,%)  902 (NA) 639 (70.7) 109 (12.0) 154 (17.3) 
Male (N,%) 355 (39.3) 249 (38.0) 35 (32.1) 70 (45.5) 
Female (N,%) 547 (60.7) 390 (61.0) 74 (67.9) 84 (54.5) 
Age (mean±SD) 11.6 ±3.32 11.8 ±3.2 12.2 ±3.2 10.3 ±3.5* 
BMI (mean±SD) 33.4 ±8.12 34.9 ±8.2† 33.1 ±7.1* 27.6 ±5.0*† 
Vitamin D (mean±SD) 18.3 ±6.9 16.7 ±7.5† 24.4 ±8.4* 20.3 ±8.3*† 
A1C (mean±SD) 5.7 ±0.5 5.8 ±0.5 5.6 ±0.3* 5.6 ±0.3* 
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Table 4-4. Multiple regression model for variables to A1C in overall sample 
 
Model Coefficient std Error t p-Value 
Constant 4.967 0.163 30.419 0.000 
Caucasian -0.204 0.490 -4.168 0.000* 
Hispanic -0.214 0.043 -4.912 0.000* 
Gender -0.026 0.031 -0.852 0.395 
BMI 0.000 0.002 0.217 0.828 
Vitamin D -0.002 0.002 -1.033 0.302 
Fasting Glucose 0.110 0.002 6.613 0.000* 
* Variables with significance at <0.05 
** R-square=0.098 
 
 
 
Table 4-5. Pearson correlation for individual variables to A1C in African 
American group 
 
Variable Coefficient std Error t p-Value 
Gender -0.069 0.041 -1.679 0.094* 
Age -0.004 0.006 -0.637 0.525 
BMI 0.002 0.002 0.666 0.505 
Vitamin D -0.003 0.003 -1.053 0.293 
Fasting Glucose 0.001 0.002 5.805 0.000* 
Fasting Insulin 0.002 0.001 2.420 0.016* 
* Variables with significance at <0.20 
 
 
 
Table 4-6. Multiple regression model for A1C in African American group 
 
Model Coefficient std Error t p-Value 
Constant 4.955 0.167 29.683 0.000 
Gender -0.043 0.040 -1.061 0.289 
Fasting Glucose 0.011 0.002 5.105 0.000* 
Fasting Insulin 0.001 0.001 0.681 0.496 
* Variables with significance at <0.05 
† R-square=0.053 
4 
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Table 4-7. Pearson correlation for individual variables in A1C in Caucasian 
group 
 
Variable Coefficient std Error t p-Value 
Gender 0.024 0.068 0.353 0.725 
Age -0.023 0.010 -2.369 0.020* 
BMI -0.001 0.004 -0.256 0.798 
Vitamin D -0.004 0.003 -1.249 0.215 
Fasting Glucose 0.016 0.004 4.127 0.000* 
Fasting Insulin 0.006 0.001 3.977 0.000* 
* Variables with significance at <0.20 
 
 
 
Table 4-8. Multiple regression model for Caucasian group 
 
Model Coefficient std Error t p-Value 
Constant 4.779 0.320 14.944 0.000 
Age -0.025 0.009 -2.829 0.006* 
Fasting Glucose 0.012 0.004 3.214 0.002* 
Fasting Insulin 0.006 0.001 4.303 0.000* 
* Variables with significance at <0.05 
† R-square=0.288 
 
 
 
Table 4-9. Pearson correlation for indiviudal variables in Hispanic group 
 
Variable Coefficient std Error t p-Value 
Gender -0.024 0.047 -0.520 0.604 
Age 0.005 0.007 0.712 0.478 
BMI 0.002 0.005 0.342 0.733 
Vitamin D -0.002 0.004 -0.451 0.653 
Fasting Glucose 0.007 0.003 2.078 0.039* 
Fasting Insulin <0.000 0.000 0.534 0.594 
* Variables with significance at <0.20  
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Table 4-10. Simple regression model for Hispanic group 
 
Model Coefficient std Error t p-Value 
Constant 5.046 0.260 19.420 0.000 
Fasting Glucose 0.007 0.003 2.078 0.039* 
* Variables with significance at <0.05 
** R-square=0.027 
 
 
Discussion 
 
 The results from this study underline the multi-dimensional causes of diabetes and 
prediabetes and further stress the difficulties in predicting the diseases.  Factors 
influencing glycemic control and A1C vary between individuals and racial/ethnic groups 
and, in some racial groups, among genders.  Previous attempts to examine these factors 
have concluded similar results; the causes of diabetes and prediabetes are multifaceted, 
often individualized, and often difficult to ascertain. 
 
 The results did support previous work that found statistically significant 
differences and variation in A1C among racial and ethnic groups.  Herman et al. 2007 
and Kirk et al. 2008 suggest biological variations across these groups with respect to 
testing.  This research supports the concept that a biological and possible genetic 
component is responsible for the variation in A1C.   
 
 Further research is needed to more accurately examine the impact of vitamin D on 
A1C.  Forouhi et al. (2008) showed a strong inverse relationship between A1C and 
vitamin D levels.  The average vitamin D level of the sample (n=24.3 ng/ml) is consistent 
with deficient vitamin D levels.  As outlined in Table 4-11, ANOVA showed 
significance differences in vitamin D levels between racial and ethnic groups, which 
supports previous research.  However, the factor lacked variance throughout the 
aggregate sample when attempting to correlate vitamin D levels and A1C.  As a result, 
statistical analysis was unable to definitively show a relationship between A1C and 
vitamin D levels.  
 
 Age was not significantly associated with A1C among the African American or 
Hispanic groups, but was weakly and inversely associated in the Caucasian group.  On 
average, the Caucasian group was the oldest (12.2 yrs) compared to their counterparts.  
The inclusion of younger, prepubescent youths in the study may account for the weak 
association between A1C and age.  Recent research has shown puberty acts as an 
accelerator for diabetes and prediabetes, due to hormone shifts (Cho, Craig & Donaghue, 
2014). 
 
 The sample had a higher percentage of females versus males. An independent t-
test comparing A1C between males and females showed no statistically significant 
differences between the gender groups when looking at the aggregate sample.  No 
research was found that supports a significant difference in A1C between genders in  
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Table 4-11. Pearson correlation:  Insulin sensitivity indices and beta-cell function 
to A1C 
 
Value A1C INS0 CIR30 IGI CISI QUICKI HOMA 
r-value 1 0.058 -0.069* 0.031 -0.145* -0.072* 0.070* 
p-value  0.081 0.040 0.356 0.000 0.031 0.036 
N 902 902 902 902 902 902 902 
* Correlation significant at the 0.05 level (2-tailed). 
 
 
children or adolescence.  As a result, this test supports the finding that a difference does 
not exist in this population. 
 
 The research did show a stronger relationship between β-cell function and A1C 
than insulin sensitivity and A1C. This relationship is consistent with previous research 
that found similar results.  The pathophysiology of the disease process is most likely to 
explain this relationship.  A decrease in insulin sensitivity can be compensated by an 
increase in β-cell function to a point.  At some point, the β-cells will no longer 
compensate for the lack of insulin sensitivity.  It is at this point glycemic control will 
shift; glucose concentrations and A1C will rise.   
 
 The results validate the previous conceptual framework noted in Figure 1-1.  The 
conceptual model notes glycemic control and the subsequent A1C result from a variety of 
factors, including race/ethnicity, insulin resistance, age, gender, vitamin D, and BMI.  
Family history, infection, hormonal, autoimmune disorders, diet, magnesium deficiency, 
and physical activity were not included in the study, research suggests these factors 
impact A1C.  Additional research should focus on addressing the factors not addressed in 
this research study in order to study more fully the factors influencing glycemic control. 
 
 The research was limited due to sample characteristics.  The sample was 
predominately overweight and African American.  In addition, the sample was 
predominately deficient in vitamin D (n=24.3 ng/ml).  A lack of variance in several 
factors limited conventional approaches to statistical analysis.  Results were required to 
be stratified by race/ethnicity to obtain results that were not skewed or biased. 
 
 In summary, race/ethnicity, fasting glucose, and fasting insulin correlated to A1C 
in the sample.  However, multiple regression provided models that explained little 
variation in the A1C.  Additional variables, such as family history, infection, hormonal 
status, autoimmune disorders, diet, magnesium deficiency, and physical activity should 
be tested and possible added to the model to increase the validity of using proxy variables 
to predict A1C in children and adolescents.          
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CHAPTER 5.    SUMMARY 
 
 
This study examined the use of A1C testing for the diagnosis of diabetes and 
prediabetes in a predominately minority sample of children and adolescents at risk for the 
development of the diseases.  The use of A1C versus OGTT testing showed some 
advantage in the screening process.  The test had a high level of specificity and negative 
predictive value, which indicates it is able to correctly identify disease-free individuals.  
Multiple regression testing highlighted the complexity of glycemic control, with minimal 
variation explained by the factors examined.  In addition, variation was found among the 
racial and ethnic groups. 
 
 
Implications for Clinical Practice 
 
 As noted, A1C testing was able to correctly identify individuals in this sample 
who were disease free.  However, it had lower abilities to identify individuals with the 
disease, as noted by the lower sensitivity and positive predictive value.  Using the A1C as 
a first step screening tool could better identify individuals needing additional diagnostic 
testing with the OGTT.   
 
The OGTT is a costly and time consume test to perform.  It requires fasting, takes 
multiple serum samples, and takes an average of 4 hours to complete.  Adding an annual 
A1C test as a screening tool to at-risk children and adolescents, could save time and 
resources by more accurately identify those individuals at risk.  By eliminating children 
with lower A1C, in spite of noted risk-factors, such as obesity, health care providers 
could focus on children with higher A1C for diagnostic testing.   
 
Children and adolescents without noted risk factors could also be screened 
annually for A1C.  A1C fingerstick testing is available, which is minimally invasive and 
can be performed outside the clinic setting.  Although this testing should be followed up a 
serum A1C test, it has potential to accurately identify youth needing additional screening 
in a community setting.  
 
 The use of A1C in children and adolescents shows promise as a screening tool for 
at-risk youths.  The sample included only a small percentage of children under the age of 
6 years, which made statistical analysis for that age group unfeasible.  However, the use 
of A1C testing showed the ability to apply the test as a screening tool for older youths at 
risk for the disease based on ADA criteria. 
 
 Due to the limited number of children testing positive for diabetes, ROC curve 
analysis was only performed to test A1C cut-off points for prediabetes.  A1C cut offs for 
Caucasian and Hispanic youths was determined to be 5.6%, which is consistent with the 
2014 ADA guidelines.  However, the cut-off for the African American group was 5.7%, 
which indicates African American youths need a higher cut-off or additional screening 
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when diagnosing a child or adolescent with prediabetes.  Additional research is needed to 
test cut-off points for diabetes diagnosis using A1C.  
 
 Research shows glycemic control is multifaceted.  Factors affecting glycemic 
control often manifest differently among racial and ethnic groups, and can even change 
across a person lifespan.  This study validated the concept factors affecting glycemic 
control are difficult to gauge.  Multiple regression analysis was not able to explain 
variation in different racial and ethnic groups.  Although limitations were present which 
prohibited part of this analysis, it is possible that this variation is so individualized that 
attempting to predict glycemic control with a set criteria is not possible.  Glycemic 
control may vary too widely between individuals to accurately predict disease with a set 
of factors.  
 
 This study showed A1C are more closely correlated to beta cell function rather 
than insulin sensitivity.  This result is consistent with previous research (Hanson et al., 
2000; Heina et al., 2012).  It is feasible to assume this correlation is due to the 
pathophysiological chain of events that occurs during the development of diabetes.  
When insulin sensitivity is diminished, beta cells often increase function in order to 
compensate.  This compensation results in appropriate glycemic control, until a time that 
the beta cells are no longer able to function at a high level.  Once beta cell function 
decreases, glycemic control is no longer able to take place, and A1C rise.  This response 
is reflected in the higher correlation between A1C and beta cell function in the study. 
 
 
Implications for Conceptual Framework 
 
 Figure 1-1 outlines the factors affected glycemic control.  According to the 
conceptual framework, glycemic control is a multifaceted concept.  Although this 
research did not examine all available factors affecting glycemic control, several key 
factors were examined.  The results of multiple regression modeling verified the general 
construct behind the conceptual map; the mechanisms of glycemic control are difficult to 
predict. 
 
 Individuals have varying degrees of ability for glycemic control.  One factor is not 
enough to predict the presence of disease, nor are factors particularly constant from one 
individual to the other.  This variation makes the process of predicting disease presence 
and progression difficult for the health care provider.  Individuals typically have multiple 
factors influencing glycemic control.  Often adjusting one or more factor can impact 
disease presence or progression, however, individual variability exists 
 
 Based on the conceptual framework, health care providers must be cognizant of 
the various factors, assess for each factor individually, and provide an individualized plan 
of care for each client.  Plans of care must address factors that can be modified and those 
factors that cannot be modified.  Health care providers should be aware that plans must 
assume the individual nature of the disease and address each patient accordingly. 
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Implications for Policy 
 
This study shows significant diagnostic ability when using the A1C to determine 
the need for additional diagnostics testing.  Current recommendations by the American 
Diabetes Association suggest A1C can be used independently from the 2-hour oral 
glucose tolerance test (OGTT) to diagnose diabetes (ADA, 2014).  However, this 
research suggests low sensitivity for the A1C test when compared to the gold standard, 
OGTT, and it shows variance between racial and ethnic groups. 
 
This study calculated the sensitivity, specificity, positive predictive value, and 
negative predictive value of using the A1C compared to the OGTT.  In addition, the 
study examined the differences of the results between African Americans, Hispanics, and 
Caucasians.  Although the results indicate low sensitivity and positive predictive value 
for the A1C, negative predictive values range from 92.8%-98.3% for diabetes diagnosis 
and 87.0%-97.7% for prediabetes diagnosis, using the cut-off points suggested by the 
American Diabetes Association (ADA, 2014).  The significance of the higher negative 
predictive value is that threshold limits can be established to use A1C testing as a 
screening tool for additional diagnostic testing.  Receiver operator characteristic (ROC) 
analysis suggests a cut-off of Hg A1C level of 5.6% for Caucasian and Hispanic 
individuals and 5.7% for African American for prediabetes diagnosis. By only 
performing OGTTs on youths with A1C higher than 5.6% in Caucasian and Hispanic 
individuals and 5.7% in African Americans, analysis suggests a negative predictive value 
of 99.9% of individuals with diabetes and 99.8% of individuals with prediabetes.  By 
using the A1C test as a screening tool, fewer youths will need to undergo the OGTT, 
which is time-consuming, costly, and poses higher risk to the individual. 
 
 This research should be presented to the clinicians, stakeholders, and vested 
associations.  Policy change should initially be sought from the association with the 
greatest stake in the policy (Longest, 2010).  Most clinicians follow the American 
Diabetes Association’s Guidelines for Diagnostic Care, which are published annually 
following extensive reviews of research. This organization is the primary stakeholder for 
enacting policy change regarding diagnostic testing for diabetes and prediabetes.  
Additional data on cost-analysis, benefit-harm analysis, and public perception of the 
policy are needed to show potential benefits to change.  By initially lobbying the 
American Diabetes Association and then the American Academy of Pediatrics, the 
greatest impact could be met.   
 
 This study suggests great promise for future diabetes research and policy 
formation regarding diagnostic testing.  If the research can be replicated in a more 
representative sample, the process by which individuals are tested for the disease could 
change.  As a result, the process for diabetes diagnosis could be less costly, less time 
consuming, and be performed with less risk to the individual.  An evidence-based policy 
change supported by national stakeholders could revolutionize the process of diabetes 
and prediabetes diagnosis. 
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Limitations 
 
 Limitations existed in this study.  The sample was retrieved from a database of 
medical records.  All participants within a set time frame were examined.  The sample 
was predominately African American and female.  Statistical analysis during multiple 
regression eliminated the African American group due to estimate biases in the sample.  
Multiple regression of the entire sample was not possible.   
 
 Additional research is needed to examine the research questions with a more 
representative sample of children and adolescents, including youth not deemed at-risk for 
the disease according to ADA criteria.  In addition, a sample more evenly divided based 
on age, racial and ethnicity, and BMI could be used in future studies.  
 
 
Conclusion 
 
 Using A1C as a screening tools is a feasible screening measurement tool, but 
follow up is needed by way of OGTT for diagnosis of disease presence.  The test could 
be used to screen youth for further testing.  However, health care providers must exercise 
clinical judgment when a negative A1C result is found in the presence of multiple risk 
factors for the disease.  Additional diagnostic testing or multiple A1C tests may be 
employed if clinical judgment or additional risk factors for diabetes or prediabetes 
indicate the presence of the disease.  
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